First Day of Classes for Second Year Students

• Date: 09 Sep
• Location: Tuck School
• Time: 8:30 a.m.

Monday, September 9, 2013 is the first day of classes for members of the Tuck Class of 2014.

First Day of Classes for T’15s

• Date: 02 Sep
• Location: Tuck School
• Time: 8:30 a.m.

Monday, September 2, 2013 is the first day of classes for members of the Tuck Class of 2015.

Tuck Class of 2015 Orientation Program

• Date: 30 Aug
• Location: Tuck School
• Time: 8:00 a.m. to 8:00 p.m.

The Orientation Program for the class of 2015 is an essential introduction to the people, opportunities, and services that will make your two years at Tuck an outstanding experience. Through lectures, interactive sessions, experiential learning, and social events, we will provide an introduction to your two years at Tuck that will be both informative and inspirational. The program changes every year and is managed by the MBA Program Office.

Orientation is the first time your class will be together on campus, and you’ll find the experience provides the platform for a lifelong network of colleagues and friends. Although the week is designed for you to get to know your full class, as many of the activities are programmed according to your fall-term section and small-group assignments.

The week will include sessions focusing on how to work in your fall study group; what to expect from faculty and the core classes; and the Tuck Codes of Conduct–the Honor Principle and the Social Code. You will refine your résumé with your peers and associates from the Career Development Office, gain a better understanding of the job search process, and learn more about the various industries related to your career search. The Center for Business and Society will organize a day of service in the Upper Valley working in small groups. This opportunity will give you the chance to meet more classmates as well as make a difference in your new community. There will also be time to socialize with your classmates during free breaks as well as the small-group dinners the MBA Program Office will coordinate.

Dartmouth College Commencement

• Date: 09 Jun
• Location: Dartmouth College Green
• Time: 9:30 a.m.

A Dartmouth ceremony for all undergraduate and graduate schools during which students receive their diplomas. The academic procession begins at 9:30 A.M., rain or shine, and the ceremony lasts about three hours. For those guests wishing to avoid heat, sun, or rain; closed circuit television viewing will be provided in several indoor locations. Admission is free and you do not need tickets for admission.

Tuck Investiture Ceremony

• Date: 08 Jun
• Location: Tuck Circle (Leede Arena - Rain)
• Time: 2:30 p.m.

This is a ceremony for graduating Tuck students and their guests during which awards are presented and master hoods are conferred. The ceremony will take place from 2:30-4:30 P.M. in the Tuck Circle with a reception to follow in Byrne Courtyard. In the event of rain, the ceremony will be Leede Arena. Admission is free, and there will be plenty of room for all guests.

First Year Project Presentations

• Date: 31 May
• Location: Tuck School
• Time: 9:00 a.m. to 6:30 p.m.

The First-Year Project course (FYP) is an educational experience in which teams of five Tuck students apply classroom learning to complex, real-world business challenges for clients. Under the guidance of an experienced faculty advisor, student teams learn practical consulting skills while their clients—ranging from early-stage startups to nonprofits to global industry leaders—benefit from the student’s experience and study at the leading edge of business education.

The FYP course has three objectives:

To learn project management skills
To apply the academic knowledge acquired in the first year to a real business problem
To tailor the curriculum to the needs and interest of each student

The ability to deliver insightful recommendations on challenging business problems in a short period of time is a vital skill for anyone in business. The FYP is an ideal time to learn these project management skills, since the projects are done for real clients over a short period of time. Faculty Advisors work with the FYP teams to help them learn specific project management skills such as defining the key question, developing an issue tree, work planning, and storyboarding.

The FYP also helps students to apply to the real world the classroom knowledge they have acquired over the preceding seven months at Tuck. Most projects draw on one or two courses heavily, and all of them draw on
the general business knowledge students pick up in their first year. Among the core courses that are most heavily used are Marketing, Managerial Communications, Strategy, and Micro Economics.

Finally, the FYP provides many students with an opportunity to tailor the curriculum to their own interests and career goals. For example, many teams develop business plans for products or services students intend to develop into a business after graduating. Other students pursue interests in real estate, sustainable business, healthcare, or other fields by creating a project in that area. Some projects lead directly to summer internships or permanent jobs.

For more information, please visit: http://www.tuck.dartmouth.edu/mba/required-curriculum/first-year-project

Final Day of Spring Term Classes

• Date: 24 May
• Location: Tuck School
• Time: 8:00 p.m.

Thursday, May 23, 2013 is the final day of courses for the spring term.

Class Visitor: Neil Castaldo, Senior Advisor - Dartmouth Hitchcock Medical Center

• Date: 22 May
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Neil Castaldo is the Senior Advisor for Dartmouth-Hitchcock Medical Center. He will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. He will speak on the topic of legal issues in health care leadership.

Neil Castaldo is Senior Advisor of Dartmouth-Hitchcock. Prior to joining Dartmouth as General Counsel in 2009, he provided legal representation to Dartmouth-Hitchcock for many years as a Partner at Hinckley, Allen & Snyder LLP in Concord, New Hampshire.
Mr. Castaldo has been cited in The Best Lawyers in America and Woodward and White as a leading lawyer in the fields of Corporate Law and Health Care Law. His interests in health care and education have led him to serve as Chairman of the Boards of The Friends Program, Central New Hampshire Community Mental Health Center, New England College and the New Hampshire Humanities Council.

Mr. Castaldo received his Juris Doctor from Vanderbilt University in 1970, where he was Case Note Editor for the Vanderbilt Law Review. He received his undergraduate degree from Dartmouth College. He is a member of the New Hampshire and American Bar Associations and the American Health Lawyers Association.

Class Visitor: Dr. Ross Jaffe (D’80), Co-Founder and Managing Director - Versant Ventures

• Date: 16 May
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Ross Jaffe specializes in early-stage investing in medical devices at Versant Ventures, a leading healthcare-focused venture capital firm. Ross co-founded Versant Ventures in 1999 after spending nine years at Brentwood Venture Capital where, as a general partner, he led investments in medical devices, drug delivery, and healthcare information systems companies.

Ross is trained as an internal medicine physician, having attended medical school at Johns Hopkins and completing his residency training at the University of California, San Francisco, where he remained a part-time physician until 1995. He also holds an MBA from Stanford.

During his more than twenty-two years in venture capital, Ross has served on the boards of a number of successful life science companies, including Acclarent, St Francis Medical Technologies, Ablation Frontiers, Insulet, Therasense, and Novacept.  He currently serves on the boards of Alter-G, Cerephex, Intersection Medical, Minerva Surgical, Portaero, and Sympara. Ross has been recognized as a leading healthcare venture capitalist, including being the highest ranked medical device investor on Forbes Magazines’ “Midas List” of the top 100 venture capitalists in both 2011 and 2012.

Active in the healthcare venture capital community, Ross is a Director of the National Venture Capital Association (NVCA) as well as a member of the NVCA Medical Industry Group and the NVCA Medical Innovation and Competitiveness Coalition (MedIC). He chairs the Board of the Children’s Health Council (Palo Alto, CA), and serves on the Board of Overseers of the Geisel School of Medicine at Dartmouth and the Board of Advisors of The Dartmouth Institute for Health Policy & Clinical Practice.

Class Visitor: Nancy Morden, MD/MPH - Associate Professor, The Dartmouth Institute for Health Policy & Clinical Practice

• Date: 15 May
• Location: Shapiro Classroom, Tuck School
• Time: 3:00 p.m.

Dr. Nancy Morden is a family physician, pharmacoepidemiologist and associate professor in the Department of Community & Family Medicine and in The Dartmouth Institute for Health Policy & Clinical Practice. Dr. Mordent will serve as a visiting executive in Professor Paul Gardent’s and Mike Zubkoff’s Structure, Organization and Economics of the Health Care Industry spring elective course. Dr. Morden will speak on the topic of “Legal & Ethical Issues in Supplier/Provider Relations.”

Dr. Morden received her Medical Degree at Harvard Medical School and completed her residency at the University of Minnesota. At the Dartmouth Institute she has developed and leads a prescription drug research team focused on the in study of population level drug use. Here principal datasets include Medicare Part D prescription drug claims and an all-payer pediatric dataset for New England. Her research focuses specifically on the impact of prescription benefits design on prescription use, on health effects associated with specific medication classes and on claims-based measures of prescribing quality. As a member of the Dartmouth Atlas of Healthcare team, she leads efforts to study variations in end of life health care intensity among patients dying with advanced cancer and is collaborating in the development of an Atlas on prescription drug use intensity.

Growing Waistlines, Growing Profits: Who Should Be Looking Out for America’s Health in a World of Processed Food?

• Date: 15 May
• Location: Cook Auditorium, Tuck School
• Time: 4:30 p.m.

Growing Waistlines, Growing Profits
Who Should Be Looking Out for America’s Health in a World of Processed Food?

Wednesday, May 15th, 2013
Cook Auditorium, Tuck School of Business
4:30pm – 6:00pm: Screening of Hungry for Change
6:00pm – 7:30pm: Panel Discussion and Q&A
Opening remarks by Dean Paul Danos,
Moderated by Professor Paul A. Argenti

Should consumers and regulators tolerate corporations that grow profits by growing Americans’ waistlines? Michael Moss’s highly-publicized book, Salt, Sugar, Fat, among others, has reignited public debate about how large food companies may be contributing to the general decline in health of the U.S. population, including the obesity epidemic. It may sound like science fiction, but menu items such as the 3,000 calorie “Bloomin’ Onion” have been engineered by food scientists to perfectly hit the bliss point of consumer’s taste buds and trigger an unstoppable desire to consume. Due to the overabundance of dietary choices available in the marketplace, critics allege that food companies can only increase sales by encouraging consumers to eat larger and more frequent meals. Industry supporters contend that they are helping busy people more conveniently feed themselves and their families, and that they are working to increase the nutritional content of their food. providing busy consumers with convenient and affordable food options while balancing the tradeoff of nutritional content and taste.

Are the arguments against food companies even true or fair? Also, how can business leaders in any industry balance their responsibility to multiple stakeholders—shareholder, consumers, and regulators—with competing and contradictory interests? This panel discussion will provide a reality check. Panelists will include:

Paul A. Argenti
Professor of Corporate Communication at The Tuck School Of Business
Panel Moderator

David L. Katz, MD, MPH, FACPM, FACP
Founding Director, Yale University Prevention Research Center

Christopher Koller
Health Insurance Commissioner, State of Rhode Island

Richard Starmann
Former Head of Corporate Communication at McDonald’s

Lisa Sutherland, Ph.D.
Assistant Professor of Pediatrics and Senior Nutrition Scientist with the Hood Center for Families and Children at Dartmouth Medical School
Former Vice President of Nutrition at Kellogg Company

Class Visitor: Wayne Roe - Managing Director, InCube Ventures

• Date: 14 May
• Location: Shapiro Classroom, Tuck School
• Time: 4:45 p.m.

Wayne pioneered the field of new product reimbursement planning and is widely recognized as America's foremost expert on third party payment and pharmacoeconomic strategy for new drugs, biologics and personalized medical therapies products.

Wayne was the founding officer and chairman of Covance Health Economics and Outcomes Services, Inc. from 1988 through 1999. Prior to that, he served as vice president for Economic and Health Policy for the Health Industry Manufacturers Association. He has been an advisor on health policy and medical innovation to the U.S. Congress, the Medicare Program and the Blue Cross Association. Wayne played a major role in developing and executing successful commercialization and reimbursement strategies for EPO, GCSF, Alfa Interferon, Ceredase, Enbrel, MRI imaging, laparoscopic surgical procedures, and scores of other blockbuster life sciences innovations.

Wayne has served on Boards of more than a dozen innovative life sciences companies over the last 20 years. He currently sits on the Boards of Directors of ISTA Pharmaceuticals, Celera Genomics, Hemaquest Inc., Fe2, Intrapace and Spinal Modulation. He is a strategic advisor to the Maryland Life Sciences Incubator, and serves on the executive committee of the Maryland Angels Investment Fund.

Ashifi Gogo, TH’10; Founder and CEO of Sproxil, to Speak at Dartmouth

• Date: 10 May
• Location: Thayer School of Engineering - Spanos Auditorium, Cummings Hall
• Time: 3:30 p.m.

Abstract: With over $600 billion in counterfeit goods sold annually per World Customs Organization estimates, significant efforts have been made to invent technologies that help differentiate between genuine and fake items. However, cunning and well-resourced counterfeiters have gained a reputation of ingeniously cracking and bypassing complex technologies through various technical and psychological means.

The speaker will examine a variety of attack vectors counterfeiters have devised to defeat anti-counterfeiting solutions implemented on multiple continents, including new unsuccessful attempts to beat Sproxil’s Mobile Product Authentication™ (MPA™) solution.

Ashifi Gogo founded Sproxil® in 2009 and currently serves as the company's Chief Executive Officer. Under his leadership, Sproxil developed its award-winning Mobile Product Authentication™ (MPATM) technology that has been used on over 100 million products by more than 2 million consumers to verify the authenticity of their medication. Former U.S. President Bill Clinton described Sproxil as “a genuinely remarkable achievement... (it's) empowering...putting people in charge of their own healthcare.” Ashifi's work has been recognized through a variety of awards and fellowships. Most recently, Sproxil was named the world’s most innovative company in health care by Fast Company, and #7 most innovative worldwide, beating 99 of the Fortune 100 companies.

Ashifi was also inducted into the 40 Under 40 Class of 2012 by the Boston Business Journal. He received a Clinton Foundation Global Initiative Outstanding Commitment Award, led Sproxil to win a grant from the United States Agency for International Development and attract venture funding from Acumen Fund in New York.

Ashifi is Six Sigma Black Belt certified in Good Manufacturing Practice and Continuous Process Improvement. Ashifi holds one US Patent and is also a named inventor on multiple published US and foreign patent applications, winning a Patents for Humanity award for its significant positive humanitarian impact. He earned a Ph.D. in electrical engineering from the Thayer School of Engineering at Dartmouth College and a B.A. in mathematics and physics from Whitman College. He is Dartmouth's first ever Ph.D. Innovation Fellow.

Class Visitor: H. Gilbert Welch, M.D. - Professor of Medicine and Community & Family Medicine - The Dartmouth Institute for Health Policy and Clinical Practice

• Date: 08 May
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Dr. Gil Welch is a Professor of Medicine and Community & Family Medicine at The Dartmouth Institute for Health Policy & Clinical Practice. He will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Mr. Do will speak on the topic of "Overuse."

Dr. Welch is a general internist whose research focuses on the problems created by medicine's efforts to detect disease early: physicians test too often, treat too aggressively and tell too many people that they are sick. Most of his work has focused on overdiagnosis in cancer screening: in particular, screening for melanoma, cervical, breast and prostate cancer. He is the author of the books, Should I be Tested for Cancer? Maybe Not and Here's Why (UC Press 2004) and more recently, Overdiagnosed: Making People Sick in the Pursuit of Health (Beacon Press 2011).

Class Visitor: Scott Wallace, First President and CEO of the National Alliance for Health Information Technology

• Date: 02 May
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Scott Wallace was the first President and CEO of the National Alliance for Health Information Technology and is currently a Visiting Professor of Family and Community Medicine at the Geisel School of Medicine. He will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Mr. Do will speak on the topic of "Health IT."

Scott Wallace is a Visiting Professor of Family and Community Medicine at The Geisel School of Medicine at Dartmouth and a Visiting Professor at the University of Virginia’s Darden School of Business. He is also a Batten Fellow at the University of Virginia’s Batten Institute and serves as on the faculty for the Harvard Business School’s executive education program on Health Care Strategy.

Scott’s research focuses on employee health as a business strategy and on redefining chronic disease care. Scott works in the U.S., Europe and South America with employers, health care providers, governments and others developing new health benefit and health care models to improve health, stop the progression of chronic diseases and effectively treat chronic medical conditions including diabetes, heart disease, hemophilia and organ transplant.

Prior to his affiliations with Dartmouth and the University of Virginia, Scott was the first president and CEO of the National Alliance for Health Information Technology. During his tenure at the Alliance from 2003 until 2008, the organization broke new ground in ensuring that health care IT issues were addressed thoughtfully and fairly, with solutions built around the consensus positions that the Alliance helped the field to reach.  In addition, while at the Alliance, Scott co-founded CCHIT, the leading health care IT certification body.

In October of 2004, President George W. Bush appointed Scott as the chairman of the Commission on Systemic Interoperability, an eleven person federal commission created to develop a national health care IT strategic plan.

Scott led several technology-based companies and a business development consulting firm.  He served as president and CEO of Eichrom Industries, an advanced materials and specialty chemical company that earned a spot on Inc. magazine’s 1996 list of the 500 fastest growing companies in America; and co-founder of a venture capital fund. He started his career practicing corporate and transactional law at Kirkland & Ellis in Chicago.

Scott earned a juris doctorate from the University of Chicago Law School, a master’s degree with honors in business administration from the University of Chicago Graduate School of Business and has a bachelor’s degree in economics from Duke University.

Scott served four years as a member of the board of directors of Blue Cross Blue Shield of Tennessee, where he chaired the board’s audit committee. He has been named repeatedly to Modern Healthcare magazine’s listing of “The 100 Most Powerful People in Health Care”.

Class Visitor: Cuong Viet Do (D’88, T’89), Executive Vice President and Chief Strategy Officer, Merck, Inc.

• Date: 01 May
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Cuong Viet Do (D'88, T'89) is the Executive Vice President and Chief Strategy Officer for Merck, Inc.. He will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Mr. Do will speak on the topic of "The Changing Global Market for Health Care."

Cuong Do serves as Merck's Executive Vice President and Chief Strategy Officer.  He is responsible for both developing and executing enterprise-wide strategy and further building connections between the current and future business plans of Merck's franchises, divisions, and functions.

The Strategy Office is also responsible for Merck’s Global Health Innovation, which invests in companies to explore future growth opportunities for Merck, as well as Regulatory Integration activities.

Prior to joining Merck, Cuong served as Senior Vice President of Corporate Strategy & Business Development at TE Connectivity, one of the world’s largest providers of products and solutions that connect and protect the flow of power and data in virtually every industry.  Cuong led the ongoing evolution of TE Connectivity’s strategy and worked closely with the company’s businesses to ensure their development initiatives are aligned with the overall company vision. He also was responsible for TE Connectivity’s mergers and acquisitions efforts.

Prior to joining TE Connectivity, Mr. Do was Senior Vice President and Chief Strategy Officer for Lenovo, a global leader in personal computers. He previously was a Director (senior partner) with McKinsey and Company where he helped to build the company’s healthcare, high tech and corporate finance practices.

He holds a Bachelor of Arts degree from Dartmouth College, New Hampshire, U.S. and a Master of Business Administration from the Tuck School of Business at Dartmouth, New Hampshire, U.S. He founded Profectum Foundation as a non-profit working to train clinicians and parents on working with autistic children.  He currently or previously served on the boards of Celebrate the Children (school for children with special needs), Caring for Cambodia (non-profit working to establish the model schools for Cambodia); the National Youth Science Foundation, and the Tuck MBA Advisory Board.

Class Visitor: Seth Brooks, P.h.D. - Associate Professor of Medicine, Geisel School of Medicine and Research Biologist, Department of Veteran Affairs, White River Junction, VT

• Date: 30 Apr
• Location: Alperin Conference Room, Tuck School
• Time: 4:45 p.m.

Dr. Seth Brooks is an Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. He serves as a Research Biologist at the Department of Veteran Affairs in White River Junction, Vermont. He will serve as a visiting executive in Professor Steve Gillis', Professor Don Conway's and Professor Mike Zubkoff's Contemporary Issues in Biotechnology spring elective course. Dr. Brooks will speak on the topic of "Government - Keeping the Lid on Biotechnology Development."

Dr. Brooks received his B.A. from the University of Pennsylvania and his PhD in Integrated Biology from the University of California, Berkeley.

The primary focus of Dr. Brooks’ lab is the study of posttranscriptual regulation of TNFa. TNFa is a central mediator of inflammation and is critical to the control of infection and activation of immune response.  TNFa overexpression contributes to a number of disease states, including rheumatoid arthritis, Crohn’s Disease, and the cachexia associated with AIDS and malignancy. 

At the molecular level, TNFa biosynthesis is largely regulated at the levels of mRNA stability and translation, each of which is orders of magnitude more important than regulation of gene transcription.  The importance of TNFa posttranscriptual regulation is disease was demonstrated with the generation of mice containing a germ line deletion of the TNFa 3’UTR ARE.  Macrophages and T cells from these mice produced 3 to 10 fold more TNFa protein than their wild-type counterparts.  This effect was mediated solely through increased TNFa mRNA stability and translation.  In addition to insights into the regulation of TNF-a biosynthesis, the relevance of these mice was apparent by the spontaneous development of disease pathology indistinguishable from Rheumatoid Arthritis, Crohn’s Disease and cachexia. 

Dr. Brooks is currently studying several proteins involved in TNFa posttranscriptual regulation.  He has also initiated studies to characterize the inflammatory response to blast wave mediated traumatic brain injury and to investigate if TNFa product is an effective therapeutic intervention to treat blast wave induced traumatic brain injury.

Dr. Troyen Brennan, Executive Vice President and Chief Medical Officer CVS Caremark Corporation - Spring Term Uhrig Healthcare Initiative Speaker

• Date: 26 Apr
• Location: Borelli Classroom - Tuck School of Business
• Time: 12:00 p.m.

Dr. Troyen Brennan will serve as Tuck's Spring Term Uhrig Healthcare Initiative Speaker. Dr. Brennan is Executive Vice President and Chief Medical Officer CVS Caremark Corporation. In his role at Caremark, he is responsible for the company’s Minute Clinics, Accordant Health Care, clinical and medical affairs and health care strategy.

Dr. Brennan is a highly regarded national health care expert who has hands on experience with all aspects of the health care delivery system including, as a practicing physician, hospital administrator and leader at a top health care insurer company.

He will host a noontime talk on Friday, April 26 in Borelli Classroom at Tuck, "Innovation in a Changing Health Care Market: View from Pharmacy."

The Tuck Uhrig Healthcare Initiative Speaker Series was made possible by John and Jennifer Uhrig, both members of the Tuck Class of 1987.

Biography:

Troyen A. Brennan, M.D., M.P.H, is Executive Vice President and Chief Medical Officer of CVS Caremark Corporation. Dr. Brennan is responsible for the company's MinuteClinic, Accordant Health Care, clinical and medical affairs, and health care strategy.

Prior to joining CVS Caremark Corporation, Dr. Brennan was Chief Medical Officer of Aetna Inc. From 2000 to 2005, Dr. Brennan served as President and CEO of Brigham and Women's Physician's Organization in Boston MA. In his academic work, he was Professor of Medicine at Harvard Medical School and Professor of Law and Public Health at Harvard School of Public Health. He is a member of the Institute of Medicine of the National Academy of Sciences.

Brennan has his MD and MPH from Yale Medical School, a JD from Yale Law School and a Masters Degree from Oxford University, where he was a Rhodes Scholar. He completed his internship and residency in internal medicine at Massachusetts General Hospital.

Class Visitor: Suzie Rubin, Former Marketing Manager, Nonmalginant Pain - Medtronic

• Date: 25 Apr
• Location: Shapiro Classroom, Tuck School
• Time: 3:00 p.m.

Suzie Rubin is the Former Marketing Manager, Nonmalignant Pain, Medtronic. She will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Ms. Rubin will speak on the topic of Medical Devices.

Suzie Rubin is a medical device industry veteran who has spent years working with MBA students interested in healthcare. Suzie spent five years in product management and marketing at Medtronic, launching new implantable cardioverter defibrillators (ICDs) and managing market development efforts for the use of intrathecal morphine for chronic pain. Prior to Medtronic, she earned an MBA at Kellogg and completed an internship at Genentech. After earning a degree in zoology from Duke University, Suzie started her career as a research analyst for the U.S. Congress, Office of Technology Assessment.

Class Visitor: Kirsten Detrick, T’92 - Executive Director of Global Marketing & Commercial Development, Amgen, Inc.

• Date: 18 Apr
• Location: Shapiro Classroom, Tuck School
• Time: 3:00 p.m.

Kirsten Detrick, T'92  is the Executive Director of Global Marketing & Commercial Development at Amgen, Inc. She will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Ms. Detrick will speak on the topic of "Biotechnology: Bringing Tomorrow's Science to Today's Health Care Challenges."

Kirsten Detrick is an Executive Director of Global Marketing and Commercial Development at Amgen Inc., a leading human therapeutics company in Southern California. In this role, Kirsten is currently building commercialization strategies for Japan and emerging markets, for a molecule in Amgen’s phase 1 pipeline that is being investigated for the treatment of hypercholesterolemia. She is also leading a team that is analyzing commercial opportunities in Japan for a range of additional molecules in Amgen’s mid- to late-stage pipeline, across a wide range of therapeutic areas including oncology, diabetes, schizophrenia, inflammation and bone.

Most recently, Kirsten was Brand Lead for Prolia® (denosumab), a first-in-class human monoclonal antibody for postmenopausal osteoporosis. One of the first biologics to be targeted at primary care physicians, the product launched in June 2010 and is forecasted to achieve >$1 billion in peak global sales potential (Wall Street estimate).

Kirsten joined Amgen in 2004 as Senior Director of Enbrel® Rheumatology Sales and Marketing, leading a team of over 100 Amgen sales and marketing professionals in a joint venture/co-promote structure with Wyeth Pharmaceuticals. In addition to this role, Kirsten led dermatology (psoriasis) marketing for Enbrel® and also partnered with regulatory and clinical development colleagues to generate additional data and indications for the therapeutic.

Prior to joining Amgen, Kirsten was with Bristol-Myers Squibb (BMS). From 2002-2004, she supervised the Plavix® US primary care marketing team, in a joint venture with Sanofi-Synthelabo. Today, Plavix is the 2nd best-selling drug in any category, worldwide. Kirsten developed US commercialization plans for a BMS first-in-class anti-hypertensive drug (Vanlev™) from 1999-2002, and from 1997-1999, Kirsten developed and institutionalized a global Marketing Analysis and Planning (MAP) process for BMS. Authoring a 40+ page proprietary guidebook on the process, Kirsten and her team developed and delivered a series of weeklong instructional courses for approximately 1,000 cross-functional BMS executives worldwide. Kirsten began her career at BMS in 1991 with the Worldwide Consumer Medicines Division, working on OTC drugs including Excedrin®, Bufferin®, and Nuprin®. 

From 1987 to 1990, Kirsten was a management consultant with APM Incorporated in New York City, where she analyzed, designed and executed strategic and operational improvements for US hospitals and medical centers. In 1990, Kirsten was a Legislative Fellow for US Senate Majority Leader George J. Mitchell in Washington, DC, where she analyzed healthcare cost-containment options for a Senate sub-committee and developed Medicare and Medicaid legislative proposals. 

Kirsten earned her Bachelor of Arts (BA) in chemistry from Middlebury College and her Master of Business Administration (MBA) from the Amos Tuck School of Business at Dartmouth College.

Kirsten is a member of the Healthcare Businesswomen’s Association (HBA), and was a recipient of an “HBA Rising Star” award in 2000.

Class Visitor: Dr. Amrit Ray, T’02 - Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson

• Date: 17 Apr
• Location: Shapiro Classroom, Tuck School
• Time: 3:00 p.m.

Dr. Amrit Ray, T'02, is the Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson . He will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Dr. Ray will speak on the topic of "The Pharmaceutical Industry: Challenges and Opportunities."

Amrit Ray, MD, MBA, FCMI, serves as Chief Medical Officer for Johnson & Johnson's Pharmaceutical division, Janssen. In this capacity, Dr. Ray has primary responsibilities for ensuring the safe, effective and appropriate use of Johnson & Johnson’s 1,000+ pharmaceutical products globally, and for supporting an innovative research pipeline of new medical solutions in areas of unmet patient need.

Dr. Ray’s first priority is serving patients. He is Chair of the Global Safety Council, the organization’s most senior governance body for product safety matters with oversight for identifying, evaluating and managing medical risk for drugs, biologics, vaccines and other categories of medicines, across all disease areas from first human exposure through clinical trials and market activity. Dr. Ray leads the Global Medical Organization, including departments for medical safety, development and medical affairs for established products, and centers of special expertise, such as for Pediatric Drug Development. He served as Chief Safety Officer since 2009, and was subsequently appointed as Chief Medical Officer in 2012.

Dr. Ray is as an experienced physician with a US, EU and Asia background in medical leadership across multiple areas of pharmaceutical research. Prior to joining J&J, he served in positions of increasing responsibility at Pfizer, Inc and at Bristol‐Myers Squibb. His experience includes directing the Phase 3‐4 development, launch and commercialization of several new medicines, overseeing departments for medical affairs, safety and epidemiology, and co‐leading Pfizer’s acquisition/integration of Pharmacia. At both Pfizer and BMS, Dr. Ray was awarded distinctions for driving the development of medicines in Immunology, Cardiovascular and Women’s Health.

Dr. Ray earned B.Sc. (with Honors) in Immunology and Doctor of Medicine degrees from Edinburgh University Medical School, Scotland. He obtained bench research experience with antibodies at Sir Joseph Lister Laboratories, and clinical medicine training at Edinburgh Royal Infirmary. He began his career serving as a hospital physician delivering patient care in the UK National Health Service, and initiated his clinical research experience in obesity at the Mayo Clinic. Dr. Ray also earned an M.B.A. degree from Dartmouth College, USA and is a former McKinsey management consultant with business experience in valuation, corporate finance and M&A.

Dr. Ray has authored numerous scientific papers and been invited to advise the World Health Organization, US Agency for International Development, UK Medicines and Healthcare products Regulatory Agency, Canadian Agency for Drugs and Technologies in Health, China’s State Food and Drug Administration and a number of international expert forums on how medicines can create value and have a positive impact in the lives of patients.

Class Visitor: John Fernandez - President and Chief Executive Officer, Massachusetts Eye and Ear Infirmary

• Date: 16 Apr
• Location: Alperin Classroom, Murdough
• Time: 1:15 p.m.

John Fernandez is President and Chief Executive Officer of the Massachusetts Eye and Ear Infirmary and of its parent company, Foundation of the Massachusetts Eye and Ear Infirmary, Inc. He will serve as a visiting executive in Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Mr. Fernandez will speak on the topic of leading a complex health care organization.

Biography:

John Fernandez was appointed President and Chief Executive Officer of the Massachusetts Eye and Ear Infirmary and of its parent company, Foundation of the Massachusetts Eye and Ear Infirmary, Inc., on January 1, 2007.

Since he took the helm at the Mass. Eye and Ear, John has been focusing the leadership on a new phase of efforts to ensure and enhance its reputation as one of the finest specialty hospitals in the world. During his tenure Mass. Eye and Ear has launched a 10-year strategic plan; opened new sites including the Longwood Medical Area, East Bridgewater, Concord, Stoneham, Duxbury and Weymouth; formed new clinical alliances and collaborations with Mass General, Brigham and Women’s Hospital, Children’s Hospital, Braintree Rehab and Joslin Diabetes Center; and grown patient volume and research revenue. The Schepens Eye Research Institute joined forces with Mass. Eye and Ear in June 2011. Fernandez is President and CEO of that organization.

The last five years have seen steady increases in revenues and margins, which has and will continue to enable more investment in the Mass. Eye and Ear mission. In September of 2010, Mass. Eye and Ear's bond rating was upgraded from below investment grade to investment grade by both Moody's and S & P.

John arrived at Mass. Eye and Ear with an impressive record of leadership success at the Brigham and Women’s Hospital (BWH), serving as Vice President of Clinical Service for his last eight years there. During his 14-year tenure at BWH, he worked with chiefs of several services, enabling the hospital’s surgical specialties, radiology and pathology departments to thrive in their clinical and academic missions. John’s accomplishments are many: he has overseen major construction projects, improved services and operations, expand research programs, and achieved aggressive volume and financial goals.

A graduate of the College of Wooster in Wooster, Ohio, Fernandez received his master’s degree in Government Administration from the University of Pennsylvania. He serves as the Chairman of the Conference of Boston Teaching Hospitals and is a member of the American College of Healthcare Executives and the Healthcare Roundtable. In addition, he is a member of the American Association of Eye and Ear Centers of Excellence, a member of the Massachusetts Hospital Association's Board of Trustees, and a member of the Suffolk University Board of Trustees.

Class VIsitor: Dr. Elliott S. Fisher, Director - Dartmouth Atlas of Health Care

• Date: 11 Apr
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Elliott Fisher, MD/MPH, is the Director of the Dartmouth Atlas of Health Care; James W. Squires M.D. Professor at the Geisel School of Medicine and Director for Population Health at The Dartmouth Institute for Health Policy and Cinical Practice. He will serve as a visiting executive in Professor Paul Gardent and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Dr. Fisher will speak on the topic of accountable care organizations.

Dr. Fisher is the James W. Squires, MD Professor at The Geisel School of Medicine and Director for Population Health and Policy at The Dartmouth Institute for Health Policy and Clinical Practice. He received his undergraduate and medical degrees from Harvard University and completed his internal medicine residency and public health training at the University of Washington. He is the director of the Dartmouth Atlas of Health Care and a member of the Institute of Medicine of the National Academy of Sciences.

His research has focused on exploring the causes of the two-fold differences in spending observed across U.S. regions and health care systems, on understanding the consequences of these variations for health and health care, and on the development and testing of approaches to performance measurement and payment reform that can support improvement. The research revealed that most of the differences in spending are due not to differences in health status, preferences, prices or poverty, but rather to greater use of discretionary services, such as the use of the hospital as a site of care and specialist referrals or diagnostic tests that would not have been ordered in lower spending regions. The findings that per-capita spending -- on these services -- is essentially uncorrelated with either quality or health outcomes highlighted the potential opportunity to improve the efficiency of U.S. health care.

His current policy work has focused on advancing the concept of "accountable care organizations" (ACOs) and includes co-directing, with Mark McClellan, a joint Brookings-Dartmouth program to advance ACOs through research, coordination of public and private initiatives and the creation of a learning collaborative that includes several pilot ACO sites across the U.S.

Class Visitor: Diane Miller - Executive Director of the Virginia Mason Institute

• Date: 09 Apr
• Location: (Via Video Conference) Alperin Classroom, Murdough
• Time: 1:15 p.m.

Diane Miller is the Executive Director of the Virginia Mason Institute. She will connect via video conference to Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Ms. Miller will speak on the topic of operations management of health care organizations.

Biography:

Diane Miller is the Executive Director of the Virginia Mason Institute. Her responsibilities include the design and delivery of education and training services in the Virginia Mason Production System (VMPS) for healthcare providers and organizations. She also oversees the Center for Health Care Solutions, an innovation unit working to create a new model of healthcare delivery based on VMPS principles. Diane maintains the Virginia Mason Production System Certification and has extensive training in applying the Toyota Production System to healthcare including a study mission to Japan to the Shingijutsu Genba Kaizen. She has led many Rapid Process Improvement Workshops and has developed healthcare curriculum for the training of leaders and staff. Diane is a frequent speaker on the application of the Toyota Production System to healthcare, the Virginia Mason Production System and leading cultural change.

Class Visitor: Neil Castaldo - Senior Advisor at Dartmouth-Hitchcock Medical Center

• Date: 08 Apr
• Location: Alperin Classroom, Murdough
• Time: 1:15 p.m.

Neil Castaldo is the Senior Advisor of Dartmouth-Hitchcock Medical Center. He will serve as a visiting executive in Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Mr. Castaldo will speak on the topic of legal risks and opportunities in health care leadership.

Biography:

Neil Castaldo is Senior Advisor of Dartmouth-Hitchcock. Prior to joining Dartmouth as General Counsel in 2009, he provided legal representation to Dartmouth-Hitchcock for many years as a Partner at Hinckley, Allen & Snyder LLP in Concord, New Hampshire.

Mr. Castaldo has been cited in The Best Lawyers in America and Woodward and White as a leading lawyer in the fields of Corporate Law and Health Care Law. His interests in health care and education have led him to serve as Chairman of the Boards of The Friends Program, Central New Hampshire Community Mental Health Center, New England College and the New Hampshire Humanities Council.

Mr. Castaldo received his Juris Doctor from Vanderbilt University in 1970, where he was Case Note Editor for the Vanderbilt Law Review. He received his undergraduate degree from Dartmouth College. He is a member of the New Hampshire and American Bar Associations and the American Health Lawyers Association.

In Celebration of National Public Health Week - Money and Medicine Film Screening

• Date: 03 Apr
• Location: Filene Auditorium
• Time: 6:00 p.m.

Money & Medicine investigates the dangers the nation faces from runaway health care spending as well as the dangers patients face from over-diagnosis and over-treatment. In addition to illuminating the waste and overtreatment that pervade our medical system, Money & Medicine explores promising ways to reduce health care expenditures and improve the overall quality of medical care.

The Affordable Care Act that the Supreme Court recently upheld extends health care coverage to over 30 million uninsured Americans but actually does very little to make health care affordable. Since 1970, health care spending has grown 9.8% annually, more than twice the rate of inflation. Medical costs now consume 17.3% of our gross domestic product. That’s $8,086 for every American or about twice as much per capita as most developed countries spend.  Although we pay more for medical care than any other country, America currently ranks 19th in the world in preventable death, 26th in life expectancy, and 31st in infant mortality.

Our more-is-better approach to health care is not only failing to make us healthier, it’s threatening to bankrupt the nation. If medical costs continue to skyrocket, American industry will become increasingly uncompetitive; the government will run up increasing deficits as it struggles to fund Medicare, Medicaid, and the new subsidies that are part of the Affordable Care Act; and millions of Americans will delay or forego necessary care because out-of-pocket medical costs will become unaffordable. 

The trillion-dollar question is how can we reduce unnecessary medical spending so that we can afford to provide affordable, high quality health care to all Americans? A number of recent studies estimate that a third of all health care expenditures are unnecessary and that eliminating wasteful spending would save over 800 billion dollars a year. Since every dollar of so-called unnecessary spending is a dollar of income to a health care provider, reigning in health care spending is much more easily said than done. However, Money & Medicine adopts a unique approach to addressing this pressing medical, ethical, and financial challenge. The film was shot at two world-renowned hospitals - UCLA Medical Center in Los Angeles and Intermountain Medical Center in Utah. The dramatic doctor/patient stories the film captures at these two hospitals illustrate the powerful forces driving excessive medical care as well as proven strategies that can reduce unnecessary medical spending, such as improving the coordination of patient care, facilitating shared patient decision-making, and practicing evidence-based medicine.

At both hospitals, Money & Medicine exposes the painful end-of-life treatment choices made by patients and their families, ranging from very aggressive interventions in the ICU to palliative care at home. The film also investigates the controversy surrounding diagnostic testing and screening as well as the shocking treatment variations among patients receiving a variety of elective procedures.

Beyond the broad policy implications of the film, Money & Medicine may also prompt viewers to alter some of their own behaviors - whether it’s executing an advance directive, thinking twice about that seemingly benign screening test, or learning more about the risks, benefits, and possible outcomes of elective procedures. Ultimately, Money & Medicine puts a human face on the health care cost crisis.

Class Visitor: Dr. Peter D. Solberg - Medical Director of Dartmouth-Hitchcock Medical Center Information Systems

• Date: 02 Apr
• Location: Alperin Classroom, Murdough
• Time: 1:15 p.m.

Dr. Peter D. Solberg is the Medical Director of Dartmouth-Hitchcock Medical Center Information Systems. He will serve as a visiting executive in Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Dr. Solberg will speak on the topic of health care technology.

Peter Solberg, MD studied anthropology as an undergrad at Stanford and taught English in China in the late 1980s. He returned to the Bay Area where he attended Medical School and served as a Medicine resident at the University of California, San Francisco. He joined faculty at UCSF, interrupted by three years in Uganda working for the US Centers for Disease Control and Prevention, on HIV treatment projects...where he also caught the bug for working on information systems in healthcare. He joined the Dartmouth faculty in 2005, practicing Hospital Medicine and continuing an HIV clinic at Hitchcock’s Manchester facility. He has served in various clinician liaison roles with Dartmouth-Hitchcock’s information systems and helped spearhead the deployment of the Epic System EHR, brought “live” in April 2011. He was appointed Medical Director of Information Systems in June 2012.  He lives with his wife (also a doc) and two young sons in Etna.

Class Visitor: Mr. Charles Plimpton (T’77) - Retired Director of Health Care Finance Group; Citi Global Markets, Inc.

• Date: 01 Apr
• Location: Alperin Classroom, Murdough
• Time: 1:15 p.m.

Charlie Plimpton served as the Director of Health Care Finance Group; Citi Global Markets, Inc. He will serve as a visiting executive in Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Mr. Plimpton will speak on the topic of financial management of health care organizations, capital financing.

Biography:

Charlie retired from Citigroup Global Markets Inc. in 2012. His career was almost entirely devoted to providing investment banking services to non-profit healthcare organizations. For 31 years, he served as lead banker to major provider organizations, including: Scripps Health (CA), Sharp Healthcare (CA), Hoag Memorial Hospital Presbyterian (CA), Memorial Health Services (CA), Childrens Hospital Los Angeles (CA), Daughters of Charity Health System (CA), Legacy Health System (OR), MultiCare Health System (WA), Children’s Hospital and Regional Medical Center (WA), Swedish Health Services (WA), St. Luke’s Health System (ID), University of Colorado Hospital (CO), Exempla, Inc. (CO), and Wheaton Franciscan Services Inc. (IL). The types of engagements he managed included taxable and tax-exempt financings, merger and acquisition transactions and comprehensive asset and liability management advisory and implementation services.

Charlie received his B.A. from the University of Pennsylvania and his M.B.A. from The Tuck School at Dartmouth.

Class Visitor: Julie McCashin, Vice President for Health Services - International SOS

• Date: 29 Mar
• Location: Shapiro Classroom
• Time: 3:00 p.m.

Julie McCashin, MBA/MPH, is the Vice President for Health Services at International SOS. She will serve as a visiting executive in Professor Paul Gardent's and Professor Mike Zubkoff's Structure, Organization and Economics of the Health Care Industry spring elective course. Ms. McCashin will speak on the topic of Comparative Health Systems.

Biography:

Julie McCashin is the Vice President for Health Services at International SOS. International SOS is the leading provider of global health services to multinational organizations including two thirds of the Fortune 500 and governmental entities such as the US Department of Defense, the Department of State and the Australian Government. Julie joined International SOS in 1994 as the first U.S. employee of the holding company AEA International and has enjoyed a number roles over the years in both operations and market development. The Health Services group focuses on developing new programs designed to support the health care needs of global employee populations and health-related corporate social responsibility programs. Her travels have taken her to more than 80 countries where she has worked with organizations entering new markets to develop a strategic health management plan to leverage government health programs, private sector providers and external funding to address access to care, occupational health, productivity and regulatory compliance. Julie attended Georgetown University as an undergraduate with a degree in International Business and holds an MBA from George Washington University and an MPH from the University of Alabama at Birmingham.

Class Visitor: Dan Jantzen, CPA - Chief Operating Officer of Dartmouth-Hitchcock Medical Center

• Date: 27 Mar
• Location: Alperin Classroom, Murdough
• Time: 1:15 p.m.

Daniel Jantzen, CPA, is the Chief Operating Officer of Dartmouth-Hitchcock Medical Center. He will serve as a visiting executive in Professor Paul Gardent's Management of Health Care Organizations spring term mini-elective course. Mr. Jantzen will speak on the topic of financial management of health care organizations, operating performance.

Biography:

Dan Jantzen is currently the Executive Vice President of Operations and Chief Operating Officer at Dartmouth-Hitchcock (D-H), an academic medical center and the largest provider of health care in the State of New Hampshire.

Dan has been a member of the D-H management team since 1990 where he has served in a variety of financial positions including Vice President of Finance and Chief Financial Officer.  Prior to relocating to the Upper Valley, Dan resided in the Boston area where he was a Senior Manager in the Audit Department of KPMG Peat Marwick. Dan spent nine years with KPMG serving clients primarily in the health care, public utilities and financial services industries.  His KPMG clients included Dartmouth-Hitchcock, Boston City Hospital and Public Service Company of New Hampshire.

Dan lives in Etna, NH and has been active in Scouting, his church as well as has served on the Boards of several organizations in the Upper Valley.

Dan graduated from Northeastern University in 1982 with a B.S. in Business Administration and a concentration in Accounting.  He has been a Certified Public Accountant (CPA) for the past 27 years.

Spring Term Courses Begin for Second Year Students

• Date: 26 Mar
• Location: Tuck School
• Time: 12:00 a.m.

Spring term courses begin for Second Year students, Tuesday, March 26, 2013.

Spring Term Courses Begin for First Year Students

• Date: 25 Mar
• Location: Tuck School
• Time: 8:00 AM

Spring term courses begin Monday, March 25, 2013 for First Year Students.

Spring Break - March 11 - March 22

• Date: 25 Mar
• Location: Tuck School
• Time: 12:00 a.m.

Tuck students will be on Spring Break Monday, March 11, 2013 through Friday, March 22, 2013.

Winter Term Courses Conclude

• Date: 07 Mar
• Location: Tuck School
• Time: 12:00 a.m.

Thursday, March 7, 2013, Winter Term courses will conclude.

Robert Meade, Senior Vice President of Marketing, Product and Communications at Aetna to Speak on Critical Care: Prescriptions for Marketing With Big Data

• Date: 06 Mar
• Location: General Motors Classroom, Tuck School
• Time: 12:00 p.m.

Robert Mead is Senior Vice President of Marketing, Product and Communications (MP&C) for Aetna, Inc. He leads an integrated group that includes the Marketing, Research, Advertising, Product, Member Experience, Communications, Public Affairs, Thought Leadership, Corporate Social Responsibility and Community Relations functions as well as the Aetna Foundation.

Mr. Mead is responsible for driving the Aetna brand and effectively integrating messaging, products and services across all of Aetna’s constituents. He is a member of Aetna's Executive Committee, the senior governing body for the company.Mr. Mead joined Aetna from the Brunswick Group LLP, a leading international corporate and financial communications consulting firm. Prior to joining Brunswick, he was the President of Gavin Anderson & Co., an Omnicom subsidiary and global consulting firm specializing in financial, corporate and public affairs.

Mr. Mead received his Bachelor's degree and completed coursework for a Master's in Business Administration at the University of Texas.

He will visit Tuck to discuss the use of big data.

What’s In It For Me?: Incentive-Based Strategies for Getting People Healthy - Health Care Panel at the Tuck Business and Society Conference

• Date: 28 Feb
• Location: Tuck School - Raether Hall
• Time: 2:00 p.m.

What’s In It for Me?
Incentive-Based Strategies for Getting People Healthy

We all know. We should eat a balanced diet, engage in regular physical activity, and abstain from smoking. So why do we find this so difficult to do? And could proper incentives help?

Approximately 60% of deaths in the world today are attributable to three epidemic chronic diseases: diabetes, cardiovascular disease, and chronic lung cancer – all of which are exacerbated by unhealthy lifestyle choices. Engaging individuals to live healthier represents both a huge business opportunity and also a chance to positively impact countries threatened by rising health care costs. This panel session seeks to provide a forum for discussion on how incentive-based strategies can be leveraged to crack the code on behavior change and consumer engagement. Specific questions to be asked will include: how can we align consumer’s short term rewards with long term health? Can living healthy become cool? What players will implement incentive based strategies? And, do employers have an ethical responsibility to promote healthy living?

Session Chair: Abigail Isaacson, T'13

How did you get interested in healthcare and what is your involvement in the industry?

I find the strategic, operational, policy, and ethical questions embedded in healthcare fascinating.  I am especially interested in the role health systems play in shaping the healthcare that a community receives.  Prior to coming to Tuck, I worked at an integrated healthcare system doing strategic planning and government relations work, and loved learning about the nuances of healthcare delivery.  After graduation, I will continue pursuing my interest in healthcare delivery and will work for a healthcare system in Maine.

What was the motivation behind organizing this session?

The question of incentives runs through many aspects of healthcare, from how to pay physicians to how to motivate ourselves to be healthy.  Our team was excited to present a panel that explores how incentives change behavior, how to use incentives to generate greater value in the healthcare system, and ultimately how to create a healthier population.  Providing high-value healthcare is not just an important question for society, but is a vital concern for businesses.  We thought the Business and Society Conference was a perfect forum to explore the role incentives in healthcare play both in business and in our personal lives.

Susan Dentzer, D’77 to Address Tuck Community on Reforming the U.S. Health Care Delivery System

• Date: 25 Feb
• Location: Borelli Classroom - Tuck School
• Time: 6:30 p.m.

Susan Dentzer (D'77) is the Editor-in-Chief of Health Affairs, he nation’s leading peer-reviewed journal focused on the intersection of health, health care and health policy in the United States and internationally. Ms. Denzter was formerly the Chief Economics Correspondent and Economics Columnist for U.S. News & World Report, and previously was a senior writer at Newsweek.

Ms. Dentzer will serve as the Winter Term 2013 Uhrig Healthcare Initiative Speaker on Monday, February 25, 2013 and will address the Tuck community at 6:30 p.m. on the topic of Reforming the U.S. Health Care Delivery System. The Uhrig Healthcare Initiative Speaker Series was made possible by Jonathan M. Uhrig (T’87) and Jennifer S. Uhrig (T’87).  This speaker series brings distinguished guest speakers to Tuck to discuss critical issues related to business and healthcare.

Biography:

Susan Dentzer is the editor-in-chief of Health Affairs, the nation’s leading peer-reviewed journal focused on the intersection of health, health care and health policy in the United States and internationally. One of the nation’s most respected health and health policy journalists, she is an on-air analyst on health issues with the PBS NewsHour, and a frequent guest and commentator on such National Public Radio shows as This American Life and The Diane Rehm Show.

Dentzer is an elected member of the Institute of Medicine, the health arm of the National Academy of Sciences, and of the Council on Foreign Relations, the independent, nonpartisan membership organization and think tank dedicated to exploring the foreign policy choices facing the United States and other countries.

At Health Affairs, Dentzer oversees the journal’s team of nearly 30 editors and other staff in producing the monthly publication and web site. Health Affairs has been described by the Washington Post as the “Bible” of health policy. Its articles and their authors are frequently cited in the Congressional Record and in congressional testimony as well as in the news media.  The Health Affairs web site records more than 90 million page views annually. 

Before joining Health Affairs in May 2009, Dentzer was on-air Health Correspondent at the PBS NewsHour. From 1998 to 2008, she led the show’s unit providing in-depth coverage of health care and health policy. Prior to joining the PBS NewsHour, she was chief economics correspondent and economics columnist for U.S. News & World Report, and previously was a senior writer at Newsweek.

Dentzer’s other work in television has included appearances as a regular analyst or commentator on CNN and The McLaughlin Group. Her writing has also earned her several fellowships, including a Nieman Fellowship at Harvard University, where she studied health economics and policy, and a U.S.-Japan Leadership Program Fellowship, during which she researched the effects of the rapidly aging Japanese population.

In addition to her membership of the Institute of Medicine, Dentzer is an elected member of the National Academy of Social Insurance, a nonprofit, nonpartisan organization made up of the nation's leading experts on social insurance, is a fellow of the Hastings Center, a nonpartisan research institution dedicated to bioethics and the public interest. She is also a public trustee of The American Board of Medical Specialties, the not-for-profit organization that oversees 24 approved medical specialty boards in setting standards for board certification and maintenance of certification for the nation’s physicians. Dentzer is a member of the Kaiser Commission on Medicare and the Uninsured, and serves on the public policy advisory group to the March of Dimes.

Dentzer is a member of the Board of Directors of Research!America, the nation's largest not-for-profit public education and advocacy alliance committed to making research to improve health a higher national priority. She is also a member of the Board of Overseers of the International Rescue Committee, a humanitarian organization providing relief to refugees and displaced persons around the world. She chairs the IRC board’s Program Committee, which oversees the organization’s activities in resettling refugees in the United States and in dealing with refugees and displaced persons in roughly 25 countries. 

A graduate of Dartmouth and holder of an honorary master of arts from the institution, Ms. Dentzer is a Dartmouth trustee emerita and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the Board of Overseers of Dartmouth Medical School.  She also serves on public policy advisory boards of the Phillip Lee Institute at the University of California at San Francisco and of Johns Hopkins Health.

Dentzer, her husband and their three children live in the Washington, DC area.

Tuck Professor Punam Keller to Deliver 25th Presidential Lecture “Building Theory by Breaking Boundaries: Health and Wealth Choice-Making”

• Date: 25 Feb
• Location: 105 Dartmouth Hall with Reception to Follow in Rauner Library
• Time: 5:00 p.m.

Professor Punam Anand Keller, the Charles Henry Jones Third Century Professor of Management at the Tuck School, will deliver the 25th Presidential Faculty Lecture on Monday, February 25, 2013. Punam's talk on "Building Theory by Breaking Boundaries: Health and Wealth Choice-Making" will highlight the critical intersection of health care and consumer communication.

The lecture will be from 5 to 6 pm in 105 Dartmouth Hall, with a reception to follow in Rauner Library.

For more information on Professor Punam Keller, please visit: http://www.tuck.dartmouth.edu/faculty/faculty-directory/punam-anand-keller/.

Film Screening and Discussion: Escape Fire: The Fight to Rescue American Healthcare

• Date: 12 Feb
• Location: Rockefeller 003
• Time: 4:30 p.m.

What can be done to save our broken medical system? Filmmakers Matthew Heineman & Susan Froemke interweave dramatic personal arcs of patients & physicians with stories of leaders battling to transform healthcare at the highest levels of medicine, industry, government, even the U.S. military.

The film examines the powerful forces trying to maintain the status quo in a medical industry designed for quick fixes rather than prevention, profit-driven rather than patient-driven care. After decades of resistance, a movement to bring innovative high-touch, low-cost methods of prevention and healing into our high-tech, costly system is finally gaining ground. ESCAPE FIRE is about finding a way out of our current crisis. It’s about saving the health of a nation.

Sundance: Grand Jury Prize (Nominated)
Full Frame: Human Rights Award (Winner)
Silverdocs: React to Film Social Issue Award (Winner)
Newport Beach: Outstanding Achievement in Documentary Filmmaking (Winner)

Discussants:
Ellen Meara
Associate Professor, The Dartmouth Institute for Health Policy and Clinical Practice
Adjunct Associate Professor of Public Policy, Rockefeller Center

Charlie Wheelan D‘88
Senior Lecturer and Policy Fellow, Rockefeller Center

Siemens Corporation Company Briefing for Second Years

• Date: 11 Feb
• Location: Frantz Classroom - Tuck School
• Time: 12:10 p.m.

Description: Siemens Corporation is a U.S. subsidiary of Siemens AG, a global powerhouse in electronics and electrical engineering, operating in the industry, energy and healthcare sectors. For more than 160 years, Siemens has built a reputation for leading-edge innovation and the quality of its products, services and solutions.

With 360,000 employees in 190 countries, Siemens reported worldwide revenue of approximately $120 billion in fiscal 2011. Siemens in the USA reported revenue of $20 billion and employs approximately 60,000 people throughout all 50 states and Puerto Rico.

Recruiting On-Campus for: Targeting 2nd years, but 1st years may attend.

Candidacy requirements: PWA required

Class Visitor: Dr. Aaron V. Kaplan - Director, Dartmouth Device Development Symposia and Director of Clinical Research, Cardiology Section - Dartmouth-Hitchcock Medical Center

• Date: 04 Feb
• Location: Borelli Classrom - Tuck School
• Time: 1:15 p.m.

Dr. Aaron V. Kaplan, M.D, F.A.C.C., F.S.C.A.L.

Director, Dartmouth Device Development Symposia

Director of Clinical Research, Dartmouth-Hitchcock Medical Center

Professor of Medicine (Cardiology) , Geisel School of Medicine at Dartmouth

Dr. Kaplan founded The Dartmouth Device Symposia (3D) in 2003 to provide a forum to examine issues central to the clinical development and commercialization of medical devices. Held each year at the Woodstock Inn, Woodstock, Vermont, the Symposium brings together a small and balanced group of thought leaders from the clinical, business, governmental/regulatory, financial and legal communities. Issues are examined using a roundtable format frequently employing case study discussion. Papers emanating from the 3D Symposia have appeared in the Journal of the American Medical Association, Circulation, The Journal of the American College of Cardiology, Health Affairs, and Cardiac Catheterization and Intervention.

Dr. Kaplan is an active medical device entrepreneur who has been on the founding team of a number of venture-backed medical device companies including Tryton Medical, LocalMed and Perclose (acquired by Abbott). In addition, Dr. Kaplan has consulted to Abbott Vascular, NMT Medical, Guidant Corporation, Johnson & Johnson and was an Entrepreneur-In-Residence at Three Arch Partners. Currently, Dr. Kaplan focuses his device development efforts on Tryton Medical, Inc., a company founded to develop a side branch specific stent. Dr. Kaplan has authored more than 30 U.S. Patents.

Dr. Kaplan received a B.S. in Engineering Sciences (Cum Laude) from Tufts University, M.D. from Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.

‘A Monstrous Octopus: The Tentacles of Poverty’ - Campus and Community-wide Symposium Seeking to Enhance Understanding and Collaboration on Poverty and Social Disparities

• Date: 01 Feb
• Location: Life Sciences Center - Dartmouth College
• Time: 12:30 p.m.

In his Nobel Laureate lecture in 1964, Martin Luther King likened the evil of poverty to “a monstrous octopus [that] projects its nagging, prehensile tentacles in lands and villages all over the world.” Identifying these tentacles as they abut on health, business and global cultures and then seeking avenues to social justice and equity within our Dartmouth community and beyond, a coalition of Dartmouth students, aided by faculty and administration, seeks to engage our community in a broad-based conversation about this octopus derived from mutual interests in the arts, medicine, business and social science and from our direct engagement with affected individuals. To that end, The Geisel School of Medicine chapter of Physicians for Human Rights, the Tuck Center for Business & Society, the Nathan Smith Society and the William Jewett Tucker Foundation of the Dartmouth College are collaborating to host a campus-wide poverty symposium at Dartmouth College. This event seeks to promote awareness and understanding among all students, faculty, and members of the Dartmouth & Upper Valley communities of issues of poverty on the local, national, and global levels. It is also our hope that this symposium will yield activism and volunteerism among Dartmouth students and community members as well
as inspiration for future collaborations across Dartmouth towards the alleviation of poverty.

This symposium is made possible thanks to the contributions of the Nathan Smith Society, the student chapter of Physicians for Human Rights and the Dean’s Office of the Geisel School of Medicine, William Jewett Tucker Foundation, the Tuck Center for Business & Society, and the Upper Valley Haven.

For more information, visit our website at http://monstrousoctopus.wordpress.com/ or contact anna.huh@dartmouth.edu.

Friday, February 1st, 12:30 p.m. to 2:00 p.m., Life Sciences Center - Keynote Address by Dr. James S. Withers
Dr. Jim Withers is a professor of Internal Medicine at the University of Pittsburgh School of Medicine, and the founder of Street Medicine Institute. He is the initiator and global leader of the Street Medicine movement. Since 1992, he has been providing medical care to Pittsburgh’s unsheltered homeless population. Through an organization, Operation Safety Net, Dr. Withers makes house calls to the homeless and envisions street medicine as a mission of mercy on a global scale. As an educator, he has built a “classroom” that would allow the students to work in the reality of the alienated and excluded poor of Pittsburgh as a Street Medicine Fellow.

Michael A. Carusi, T’93 - Small Group Student Luncheon and Office Hours

• Date: 31 Jan
• Location: Lindenauer Dining Room and Mutz Conference Room
• Time: 12:00 p.m.

Mr. Michael A. Carusi (T’93), General Partner of /ATV Lifestone Ventures (http://lightstonevc.com/) will visit Tuck Thursday, January 31, 2013. He is a frequent visitor to Tuck and served as the 2012 Winter Term Uhrig Healthcare Initiative Speaker and spoke on the topic of: “Medtronic’s Acquisition of Ardian:  A Breakthrough Deal in Health Care,” in which Mr. Carusi played a key role.  Mr. Carusi focus is  in biopharmaceutical and medical device investments and he is featured on the 2011 Forbes Midas List of Top Technology Investors. He is a recognized thought leader in the industry and a frequent speaker at healthcare-related conferences and trade shows.

Mr. Carusi is serving as a visiting executive in Professor Gregg Fairbrothers and Dr. Aaron Kaplan’s course, “The Intersection of the Clinic and Commercialization: How Innovation Happens” but reached out to Development and Alumni Services to offer his time to Tuck students interested in health care, particularly in the investment sector.

Biography:
Mike is a General Partner and Team Leader of Lightstone Ventures. He focuses on biopharmaceutical and medical device investments out of the firm’s Palo Alto office. Mike joined ATV in 1998 and serves as a General Partner. His representative investments include Altura Medical, Ardian (acquired by Medtronic), EndoGastric Solutions, GI Dynamics (ASX: GID.AX), GluMetrics, Innovative Pulmonary Solutions, MicroVention (acquired by Terumo), NeuroVista, Plexxikon (acquired by Daiichi Sankyo), PowerVision, TranS1 (NASDAQ: TSON), and Second Genome.

Featured on the 2011 Forbes Midas List of top technology investors, Mike is a recognized thought leader in the industry and a frequent speaker at healthcare-related conferences and trade shows. He serves as a faculty member of the Stanford Biodesign Emerging Entrepreneurs Forum, sits on the Tuck MBA Advisory Board, and is an advisory board member to the UCSF/Berkeley Venture Innovation Program.
Prior to joining ATV, Mike served as the Director of Business Development for Inhale Therapeutic Systems (now Nektar Therapeutics, NASDAQ: NKTR), a venture-backed pulmonary drug delivery company that went public in 1994. At Inhale, Mike led partnering activities with a number of well-established pharmaceutical and biotechnology companies in the United States, Europe, and Japan. Mike also was a Principal at The Wilkerson Group, a strategic ATV partner and leading management consulting firm focused exclusively on healthcare. At The Wilkerson Group, Mike helped establish the firm’s offices in London and San Francisco.

Education:
M.B.A. from the Amos Tuck School of Business Administration at Dartmouth College
B.S. Mechanical Engineering from Lehigh University

Class Visitor: Anne M. Sullivan, T’95 - Vice President, Corporate Development, Sunovion Pharmaceuticals

• Date: 28 Jan
• Location: Borelli Classroom - Tuck School
• Time: 1:15 p.m.

Anne M. Sullivan has been with Sunovion Pharmaceuticals Inc (Formerly Sepracor Inc.)  since 1998 and is Vice President, Corporate Development. In this role, she is currently responsible for mergers and acquisition of companies and licensing of products, technologies and intellectual property in support of the company’s overall strategy.

During her tenure at Sunovion, Ms. Sullivan has managed a variety of in and out licensing negotiations, co-promotion deals, acquisitions and key corporate alliances. She has played an important role in the forward integration of the company through participation on key cross functional teams focused on strategic and product development projects for the company. She was instrumental in the acquisition of Sepracor Inc. by Dainippon Sumitomo Pharma Co., Ltd. in October 2009.

Prior to joining Sunovion, Ms. Sullivan held management positions in marketing, market research, and sales at Abbott Laboratories. Ms. Sullivan is a certified public accountant and previously held positions in audit and international finance at KPMG Peat Marwick and Wang Laboratories.

Ms. Sullivan received a Bachelor of Arts degree in Economics and Accounting from the College of the Holy Cross, located in Worcester, Massachusetts in 1988 and an MBA from the Tuck School of Business at Dartmouth College in 1995.

Class Visitor: Christina Morrison, T’93 - Senior Vice President, Business Planning - Merck

• Date: 23 Jan
• Location: Borelli Classroom - Tuck School
• Time: 1:15 p.m.

Christina Takoudes Morrison

Christina Takoudes Morrison joined Merck in November 2009. Christina leads the Business and Financial Planning Group, which provides stewardship to all Merck-wide business planning processes; overseeing the formation of the 5 Year Plan component of the Long Range Operating Plan, quarterly forecasts and Annual Budget; and supporting the Executive Committee in the ongoing management of resource prioritization and investment commitments. The Business and Financial Planning organization also includes the Global Support Functions planning, analysis, BRIDGES and the Data Warehouse and Analytics Program, TRANSIT. She joined Merck from Wyeth where she spent just over five years. Prior to leaving, she was the Senior Vice President, Chief Financial Officer of Wyeth Pharmaceuticals with direct responsibility for the finance organizations supporting global commercial operations, manufacturing, finance shared services, and global business development. Prior to that role, Christina was the Vice President, Chief Financial Officer of Wyeth U.S. Pharmaceuticals and the Vice President of New Business in Women's Health Care for Wyeth before that. Christina also served as the Director, Strategic Planning for the Rouse Company and was a Managing Director in the Health Care Group of Deutsche Bank, where she primarily worked on mergers and acquisitions for 12 years.

Christina earned her B.S. Economics from the Wharton School at the University of Pennsylvania and her M.B.A. from the Tuck School at Dartmouth College. She is also a member of the Tuck School Board of Overseers.

Disease Awareness, Prevention, and the Implementation of Health Care Programs: Lessons for East Africa

• Date: 21 Jan
• Location: Haldeman 124 - Dartmouth Campus
• Time: 2:15 p.m.

MD/MBA student, Leo M. Gribelyuk '13 Tuck/'13 Giesel, and Julia Roper '15 will be sharing their insights on Disease Awareness, Prevention, and the Implementation of Health Care Programs: Lessons from East Africa, at the 4th Annual Student Forum on Global Learning, Monday, January 21st, from 2:15 p.m. to 3:00 p.m. in Haldeman 124.

This session will focus on two different disease stories in Eastern Africa: kidney disease in Tanzania and HIV/AIDS in Uganda. The presenters will share their experiences working on projects to promote awareness and prevention throughout the populations they worked amongst. They will discuss the obstacles they faced and witnessed regarding the implementation of public health programs and they will comment on the lessons they learned and how these can be applied on a larger scale.

Leo Gribelyuk '13Tuck/'13 Geisel was born in Moscow, Russia and has lived in Uzbekistan, England, Germany and several cities throughout the United States. Leo attended New York University for his undergraduate studies and double-majored in Math and Neural Science, and is now an MD/MBA student at the Geisel School of Medicine and Tuck School of Business at Dartmouth. Leo has led international health service projects in Honduras and South America, and plans to make international work a major part of his clinical career. He is applying for a residency in Plastic and Reconstructive Surgery and has a specific interest in Hand Surgery.

Julia Roper '15 is a Psychology Major and International Studies Minor. She has volunteered in Guatemala, Haiti, and Uganda. She especially loves working with children and has a passion for serving overseas. She wants to continue working on international public health projects during her time at Dartmouth and after she graduates. She plans on attending graduate school for social work or public health.

Biogen Idec., Inc. Brown Bag Luncheon (Informational Session)

• Date: 17 Jan
• Location: Stoneman Classroom - Tuck School
• Time: 12:00 p.m.

The Tuck Career Development Office has arranged for company-specific interview preparation. Second year students have graciously volunteered their time to speak with first year students about their interview experience by company.

This session will highlight Biogen Idec., Inc.: http://www.biogenidec.com/

Tuck-Thayer Connect - Entrepreneurial Project Pitch Session

• Date: 16 Jan
• Location: General Motors Classroom - Tuck School
• Time: 12:00 p.m.

This Tuck-Thayer connection was started last year as a way to spark interactions at an early stage between new technologies coming out of Thayer and Tuck students seeking ideas to develop. Last year's impressive line-up included a new propulsion technology for vessels inspired by whale movements and a solar educational device for Nepali schools, among others.

Dartmouth's Engineering Entrepreneurship Program (DEEP) prepares students at all levels—from introductory classes to the Ph.D.—for technology leadership. The program consists of opportunities throughout the curriculum for students to acquire design, business, and leadership skills and experience the process of turning new ideas into marketable technologies.

Thayer School's integrated single department facilitates cross-disciplinary thinking, and students have direct access to entrepreneurial mentors including professors who hold numerous patents and have founded their own startup companies. In addition, DEEP utilizes collaborations with Tuck School of Business at Dartmouth, The Geisel School of Medicine at Dartmouth, Vermont Law School, and industry partners as well as numerous Dartmouth entrepreneurial resources.

Class Visitor: Dr. Kenneth I. Kaitin - Director and Professor, Tufts Center for the Study of Drug Development

• Date: 15 Jan
• Location: Borelli Classroom - Tuck School
• Time: 1:15 p.m.

Dr. Kenneth I. Kaitin will serve as a visiting executive in Professor Don Conway's Business of Healthcare winter elective course.

Kenneth I Kaitin, Ph.D.
Professor and Director
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, Tufts University

Dr. Kaitin is Professor and Director at the Tufts Center for the Study of Drug Development at Tufts University School of Medicine. He is also a visiting lecturer at the Tuck School of Business at Dartmouth College, and he serves on the faculty of the European Center for Pharmaceutical Medicine at the University of Basel. Dr. Kaitin writes and speaks regularly on factors that contribute to the slow pace and high cost of pharmaceutical R&D and the impact of efforts to speed the drug development process. He has provided public testimony before the U.S. Congress on pharmaceutical development, regulation, and policy issues, and he currently serves as an expert consultant to the U.S. Department of Defense on bioterror countermeasures initiatives. An internationally recognized expert on the science of drug development, Dr. Kaitin is frequently quoted in the business and trade press on trends in the R&D-based industry and new models of innovation. He is a former President of the Drug Information Association, and he is currently Editor-in-Chief of Expert Review of Clinical Pharmacology. He is on the editorial boards of a number of peer-review journals, and he serves on the boards of directors and scientific advisory boards of several public, private, and not-for-profit life sciences companies and organizations. In 2011, Dr. Kaitin received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators. Dr. Kaitin received a B.S. from Cornell University and an M.S. and Ph.D. in pharmacology from the University of Rochester.

Genentech Brown Bag Luncheon (Informational Session)

• Date: 15 Jan
• Location: Barclay Classroom - Tuck School
• Time: 12:30 p.m.

The Tuck Career Development Office has arranged for company-specific interview preparation. Second year students have graciously volunteered their time to speak with first year students about their interview experience by company.

This session will highlight Genentech: http://www.gene.com/

Genentech Webinar - An Overview of the Biotechnology Business

• Date: 14 Jan
• Location: Borelli Classrom - Tuck School
• Time: 5:00 p.m.

The Tuck Healthcare Club has arranged for a webinar hosted by Genentech. Members of the company’s Managed Care Marketing team will review key components of the biotechnology business, as well as provide insight into the health care summer internship interview process and positions available within the company.

Eli Lilly & Company Brown Bag Luncheon

• Date: 14 Jan
• Location: Rosenwald Classroom - Tuck School
• Time: 12:00 p.m.

The Tuck Career Development Office has arranged for company-specific interview preparation. Second year students have graciously volunteered their time to speak with first year students about their interview experience by company.

This session will highlight Eli Lilly & Company (http://www.lilly.com/Pages/home.aspx).

Winter Term Classes Begin

• Date: 07 Jan
• Location: Tuck School
• Time: 8:00 AM

Courses for the Winter Term begin.

Tuck School Winter Break (Mon. 12/24/12 - Wed. 01/02/12)

• Date: 02 Jan
• Location:
• Time:

The Tuck School and surrounding Dartmouth campus are closed for Winter Break.

Second Year December Mini Term Concludes

• Date: 14 Dec
• Location: Tuck School
• Time:

The December Mini Term concludes for Tuck Second Year students.

First Year Fall B Examinations Conclude

• Date: 13 Dec
• Location: Tuck School
• Time:

The Fall Term for members of the Tuck Class of 2014 concludes Thursday, December 13th.

Health Care in Post-Election America Alumni Panel and Reception - Princeton, NJ - Nov. 29th

• Date: 29 Nov
• Location: Princeton, NJ
• Time: 6:00 p.m.

Health Care in Post-Election America
Date: Thursday, November 29, 2012
Time: 6:00-8:00 p.m.
Location: Princeton, NJ a the Home of Lisa (Russell) Stockman T'80 and Bob Stockman T'81

With the 2012 election now decided, it is time to look to the future. Join Tuck Healthcare Initiative faculty and fellow industry alums for a thoughtful discussion on the industry outlook across sectors including health care delivery, investment, devices, and pharmaceuticals.

6:00-6:45 p.m. Cocktails and light supper
6:45-6:55 p.m. Tuck Healthcare Initiative update from Professors Mike Zubkoff and Don Conway
6:55-7:30 p.m. Alumni panel on the topic of health care in post-election America featuring:

• Mike McIvor D'86 T’93: Vice Chairman - Americas Mergers & Acquisitions, Bank of America Merrill Lynch
• Christina Takoudes Morrison T’93: SVP, Business Planning, Merck & Co., Inc.
• Robert Stockman T’81: Chairman and CEO, Reva Medical, Inc.

7:30-8:00 p.m. Reception and discussion

Please RSVP thorugh myTUCK today. We hope you are able to join us in Princeton!

All of us in Hanover send our heartfelt wishes to our Tuck family and friends on the East Coast following the destructive impact of Hurricane Sandy. Andy Steele T'79 and the Alumni Services team are available to provide support as best we can. You can reach us at tuck.alumni.services@tuck.dartmouth.edu or 603-646-3279.

Second Year December Mini Term Classes Begin

• Date: 26 Nov
• Location: Tuck School
• Time:

December Mini-Term courses for Second Year students will begin Monday, November 26th.

Tuck School Thanksgiving Recess (Wed. Nov. 21st - Sun. Nov. 26th)

• Date: 26 Nov
• Location:
• Time:

The Tuck School will be closed for the Thanksgiving holiday.

Second Year Fall Term Examinations Conclude

• Date: 21 Nov
• Location:
• Time:

Second Year Fall Term examinations conclude and the majority of students will leave campus for Winter Break unless they are participating in December mini courses.

Company Briefing for First-Year Students - CVS Caremark

• Date: 19 Nov
• Location: Tuck School - General Motors Classroom
• Time: 12:10 PM

With the 2007 merger of CVS Corporation and Caremark Rx, Inc., we became an integrated provider of prescriptions and related health services with an unmatched breadth of capabilities. Today we're the market leader in multiple categories and able to provide payors and patients with solutions that no pharmacy retailer or pharmacy benefits manager on its own could offer. For this reason, we are in a “category of one,” uniquely positioned to help people on their path to better health.

We can do this by providing end-to-end solutions that impact everything from pharmacy plan design to the ultimate delivery of products and services to customers. Our capabilities include industry-leading clinical and health management programs, specialty pharmacy expertise, leadership in retail clinics, customer service excellence, and our deep knowledge of the consumer gained through the more than five million people we serve every day, seven days a week.

What do you get when you combine the nation's largest chain of retail pharmacies, a leading PBM, and the fastest-growing operator of retail health clinics? In CVS Caremark, you get a pharmacy innovation company with the potential to have a major impact on the way pharmacy and health care services in the United States are delivered. We plan to leverage our unique combination of resources to help payors control costs more effectively, improve patient access, and promote better health outcomes in a way that no other company can.

Recruiting On-Campus For: First-Year Students

Candidacy Requirements: Permanent Work Authorization Required

David Kolstad (T’90), Vice President and General Manger of St. Jude Medical’s Cardiovascular Devision Imaging Business Hosting Small Group Student Meetings

• Date: 19 Nov
• Location: Tuck School
• Time: 12:00 p.m.

Mr. David Kolstad, T'90, will visit Tuck Monday, November 19th to meet with students over a small group luncheon and office hours. Current students are encouraged to sign-up for these activities via TuckStreams.

Mr. Kolstad is currently the Vice President & General Manager of St. Jude Medical’s Cardiovascular Division imaging business.  Mr. Kolstad previously served as President and CEO of LightLab Imaging, prior to its acquisition by St. Jude Medical.  Prior to LightLab Imaging, Mr. Kolstad was Vice President of Worldwide Marketing and served as General Manager for Hewlett-Packard’s medical imaging business.  He has also served in senior leadership roles in venture backed valve repair and other medical device companies developing products for end-stage heart failure.

David is a member of the Board of Directors and serves on the Executive Committee of the Massachusetts Medical Device Association (MassMEDIC). He began his career as a member of General Electric’s management development program and served as a Motor Lifeboat Coxswain in the US Coast Guard. 
He received his BS in Chemical Engineering from the Worcester Polytechnic Institute and his MBA from The Amos Tuck School of Business Administration at Dartmouth. Mr. Kolstad resides in Carlisle, Massachusetts with his wife Diana (T’90) and their three children.

Company Briefing - McKinsey Canadian Offices and Global Health Practice

• Date: 16 Nov
• Location: Tuck School - Borelli Classroom
• Time: 3:00 PM

Thomas Park T'10 from the McKinsey Montreal office will give a briefing on McKinsey's Canadian offices as well as the firm's Global Public Health Practice. Attire for this event is casual.

Office Hours with Thomas will follow; please sign-up on TuckStreams.

Class Visitor: Dr. Jack Wennberg - Founder and Director Emeritus, TDI

• Date: 14 Nov
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 PM

Dr. Jack Wennberg, MD/MPH

Peggy Y. Thomson Professor Emeritus in the Evaluative Clinical Sciences and Founder and Director Emeritus of The Dartmouth Institute for Health Policy and Clinical Practice.

John E. Wennberg, M.D., M.P.H., is the Peggy Y. Thomson Professor Emeritus in the Evaluative Clinical Sciences and Founder and Director Emeritus of The Dartmouth Institute for Health Policy and Clinical Practice. He has been a Professor in the Department of Community and Family Medicine since 1980 and in the Department of Medicine since 1989. Dr. Wennberg is a member of the Institute of Medicine of the National Academy of Science and the Johns Hopkins University Society of Scholars. He has received numerous awards, including the Institute of Medicine’s 2008 Gustav O. Lienhard Award, the Association for Health Services Research's Distinguished Investigator Award, the Richard and Hinda Rosenthal Foundation Award in Clinical Medicine, and the Baxter Foundation's Health Services Research Prize.

He is a graduate of Stanford University and the McGill Medical School. His post-graduate training was in internal medicine and nephrology at Johns Hopkins University, but he became interested in the application of epidemiological principles to the health care system while pursuing his Master's degree in Public Health at Johns Hopkins.

With colleague Alan Gittelsohn, he developed a strategy for studying the population-based rates of health resource allocation and utilization (small area analysis), which revealed large variations in the rates among local and regional health care markets, much of which appeared to relate to the distribution of supply of resources and to differences in local medical opinion. Together with colleagues in Maine and Boston, Dr. Wennberg undertook a series of studies designed to reduce scientific uncertainty, primarily in the area of prostate disease (where surgical procedures had been shown to vary by a factor of three or more among neighboring regions). Efforts to clarify the outcomes and the theoretical basis for undertaking prostate surgery led, in turn, to awareness of the importance of patient preference in the rational choice of treatment and to studies involving the patient as an active participant in the choice of treatment. Recent research includes a focus on the question of how many physicians are needed.

Wennberg and colleague Al Mulley are co-founders of the Foundation for Informed Medical Decision Making, a non-profit corporation providing objective scientific information to patients about their treatment choices using interactive media. In 2005, Dr. Wennberg and Dr. Mulley were co-recipients of the Picker Institute Award for Advancement of Patient Centered Care.

Dr. Wennberg is the founding editor of The Dartmouth Atlas of Health Care, which examines the patterns of medical resource intensity and utilization in the United States. The Atlas project has also reported on patterns of end of life care, inequities in the Medicare reimbursement system, and the underuse of preventive care.

Thermo Fisher Scientific Company Briefing for First Year Students

• Date: 13 Nov
• Location: Tuck School - Rosenwald Classroom
• Time: 12:10 PM

Description: Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Recruiting On-Campus for: First Year Students

Candidacy Requirements: PWA required

Company Representatives:
Brenden Beckstein, Director, Learning and Development
Anand Mamidipudi T'08, Product Line Manager

Health Care Resume Review

• Date: 07 Nov
• Location: Tuck School - Location TBD
• Time: 2:00 p.m. to 4:30 p.m.

Tuck's Health Care Club Officers welcome students interested in health care to this open session where individuals experienced with the health care recruiting process will offer guidance and insight.

Class Visitor: Regina E. Herzlinger - Nancy R. McPherson Professor of Business Administration, Harvard Business School

• Date: 07 Nov
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Regina E. Herzlinger - Nancy R. McPherson Professor of Business Administration at the Harvard Business School

Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and the first to serve on a number of corporate boards. She is widely recognized for her innovative research in health care, including her early predictions of the unraveling of managed care and the rise of consumer-driven health care, a term that she coined. Money has dubbed her the “Godmother” of consumer-driven health care.

Her views on health care were most recently profiled in an interview with Managed Care journal (July 18, 2011), HealthBlawg.com’s interview Health Care Reform and Other Health Care Innovations (July 7, 2011), and in Brazil’s Gestão em Saúde Diagnóstico (Jan/Feb/Mar, 2011). She is currently completing two text and cases books on Innovating in Health Care, one for the life sciences and the other for health care insurance and delivery.

All of her health care books have been best sellers in their categories. Market Driven Health Care (Boston: Perseus, 2000) is widely viewed as a transformational work for its introduction of the concepts of health care focused factories, which provide integrated care for diseases and disabilities, and the need for a  governmental health care transparency agency. Her latest book, Who Killed Health Care? (NY: McGraw-Hill, 2007) was profiled in a full-page article in The Economist. Her prior book, Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers (San Francisco: Jossey-Bass, 2004), received a research award and its research results were profiled by The Wall Street Journal (November 2002) and Managed Health Care Executive (June 2003, cover).

Regina Herzlinger briefed the Majority of the U.S. House of Representatives on health care at their annual retreat. She has won the Consumers' for Health Care Choices Pioneer in Health Economics award, the American College of Healthcare Executives’ Hamilton Book of the Year award twice, the Healthcare Financial Management Association’s Board of Directors award, and Management Accounting’s research prize. She was inducted as an honorary fellow by the American College of Physician Executives and Managed Healthcare named her one of health care’s top ten thinkers. In recognition of her work in nonprofit accounting and control, she was named the first Chartered Institute of Management Accountants Visiting Professor at the University of Edinburgh. She has delivered many keynote addresses at meetings of large health care and business groups and been selected by students as one of the outstanding instructors of the Harvard Business School’s MBA Program.

Professor Herzlinger has served on the Scientific Advisory Group to the U.S. Secretary of the Air Force and as a board member of many private and publicly-traded firms, mostly in the consumer-driven health care space.

Regina Herzlinger received her Bachelor’s Degree from MIT and her Doctorate from the Harvard Business School.

She has been married to Dr. George Herzlinger, her MIT classmate, for 46 years. Both their children graduated from Harvard College. Her daughter is an Endocrinologist; her son, a business man, is a decorated Infantry Captain in the U.S. Army who served two tours in Iraq, and later graduated from Harvard Business School.

Class Visitor: Greg Zobel - Chief Growth Officer, Healthrageous

• Date: 31 Oct
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 p.m.

Greg Zobel
Chief Growth Officer, Healthrageous

As Chief Growth Officer, Greg leads sales and business development at Healthrageous.  He has led sales and business development at Alere, Inc. (leading population health management firm) and ParadigmHealth, Inc. (leading innovator in complex condition management).  He began his career with American Hospital Supply Corporation / Baxter, Inc. in sales, marketing and product management where he conceived and oversaw the development of the first consumer-friendly, intravenous infusion pump.  Greg holds Juris Doctor and Masters in Business Administration degrees from the University of Denver and a Bachelor of Science degree in Nursing from the University of Virginia.

Class Visitor:  Peter Dolan (T’80) - Founder and Chairman, Child Obesity180; Former Chairman and CEO, Bristol-Myers Squibb Company

• Date: 31 Oct
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Peter Dolan is currently a founder and the Chairman of Child Obesity180, a multi sector, CEO level not for profit created to reverse the trend in Childhood Obesity. From 2009 to 2011, he was also Chairman and CEO of Gemin X, a venture capital backed oncology company that he led to a successful $500MM+ exit in April of 2011.

He sits on numerous for profit and not for profit boards, mostly in the health and wellness space. And as Vice Chair of the Board of Trustees at Tufts University, he very recently led the search committee to identify the next university president.

Prior to that, Peter worked for two large companies (General Foods and Bristol-Myers Squibb) for 25 + years. In an 18 year career with BMS, among other positions, he led the company's nutrition business as global president (Mead Johnson), the company's medical device businesses (Zimmer Orthopedics, among others) and at 45, he was named Chairman and CEO of the Bristol-Myers Squibb Company, holding the CEO position from 2001 to 2006.

Peter and his wife Katie, both Tuck '80 graduates, have two sons. For 30 years they have participated in numerous marathons and triathlons, including both completing the Hawaii Ironman in 2007. In 2009, marathons became a family affair as Peter, Katie and their two sons all completed the Boston Marathon.

Class Visitor: Dr. Elliott S. Fisher - Director, Dartmouth Atlas of Health Care

• Date: 24 Oct
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 PM

Elliott S. Fisher, MD, MPH
Dr. Fisher is the James W. Squires, MD Professor at Dartmouth Medical School and Director for Population Health and Policy at The Dartmouth Institute for Health Policy and Clinical Practice. He received his undergraduate and medical degrees from Harvard University and completed his internal medicine residency and public health training at the University of Washington. He is the director of the Dartmouth Atlas of Health Care and a member of the Institute of Medicine of the National Academy of Sciences.

His research has focused on exploring the causes of the two-fold differences in spending observed across U.S. regions and health care systems, on understanding the consequences of these variations for health and health care, and on the development and testing of approaches to performance measurement and payment reform that can support improvement. The research revealed that most of the differences in spending are due not to differences in health status, preferences, prices or poverty, but rather to greater use of discretionary services, such as the use of the hospital as a site of care and specialist referrals or diagnostic tests that would not have been ordered in lower spending regions. The findings that per-capita spending -- on these services -- is essentially uncorrelated with either quality or health outcomes highlighted the potential opportunity to improve the efficiency of U.S. health care.

His current policy work has focused on advancing the concept of "accountable care organizations" (ACOs) and includes co-directing, with Mark McClellan, a joint Brookings-Dartmouth program to advance ACOs through research, coordination of public and private initiatives and the creation of a learning collaborative that includes several pilot ACO sites across the U.S.

Fall Term Uhrig Helathcare Initiative Speaker: Mr. Peter Neupert, T’80 - Operating Partner, Health Evolution Partners and Former Corporate Vice President, Microsoft’s Health Solutions Group

• Date: 24 Oct
• Location: Tuck School - Borelli Classroom, Raether Hall
• Time: 12:00 p.m.

The Tuck Healthcare Initiative in partnership with Development and Alumni Services is pleased to announce our Fall Term Uhrig Healthcare Initiative Speaker, Mr. Peter M. Neupert, T'80. Mr. Neupert currently serves as an Operating Partner for Health Evolution Partners. Prior to Health Evolution Partners, Mr. Neupert was the Corporate Vice President of Microsoft Health Solutions Group and Founding President and Chief Executive Officer of drugstore.com.

Mr. Neupert will host a noontime talk, "Will Internet Innovation Ever Transform Healthcare – and Why You Should Care? Tales From An Early Pioneer."

Peter is currently an Operating Partner at Health Evolution Partners; a health only, middle market private equity firm founded by Dr. David Brailer. Dr. Brailer was the first National Coordinator for Health IT and created the ONC office during the Bush administration. The growth equity fund has three investment sectors; life sciences, services and IT.   Peter focuses on the IT sector.

Select Prior Experience:
Boards of Directors:
Fred Hutchinson Cancer Research Center – current Trustee
drugstore.com (CEO and Chairman of company)
GlobalScholar.com (private company sold to Scantron Corp)
Aquantive.com (public company sold to Microsoft)
Cranium, Inc. (sold to Hasbro)

Microsoft: Peter most recently served as Corporate Vice President of the Microsoft Health Solutions Group since its formation in 2005. As Corporate Vice President, Peter was responsible for driving the company’s strategy to improve healthcare around the world through software innovation. He led a global organization dedicated to developing, marketing, selling and supporting software solutions designed to improve the quality and efficiency of healthcare delivery and to empower individuals to become more engaged and responsible for their own health and wellness. From 1987 to 1998, Peter served at Microsoft in various capacities, including as the Sr. Director of Operating Systems responsible for shipping OS/2, responsibility for the Asia Pacific region, and Vice President for News and Publishing, where he started MSNBC and managed Slate.com.

drugstore.com Inc.: Peter served as the founding President and Chief Executive Officer of drugstore.com from 1998 to 2001 and as Chairman of the Board of Directors through September 2004. He took drugstore.com public in 1999 and led drugstore.com to become a top online retail store and information site for health, wellness, beauty and pharmacy products, and received an Ernst & Young Entrepreneur of the Year award for his work.

President’s Information Technology Advisory Committee (PITAC): From 2003 to 2005, Peter served on the President’s Information Technology Advisory Committee (PITAC), co-chairing the Health Information Technology subcommittee and helping to drive the “Revolutionizing Health Care through Information Technology” report, published in June 2004 by PITAC.
 

Peter was an active member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2007-2011.
He shares his observations and opinions on health in his personal blog, www.neupertonhealth.com. You can read my testimony to the Senate regarding the HiTech Act in 2009 here.

Education:
Bachelor’s degree in Philosophy, Colorado College 1978
MBA with high distinction, The Amos Tuck School of Business, Dartmouth College   1980

This event is courtesy of John and Jennifer Uhrig, both members of the Tuck Class of 1987. The Uhrig Healthcare Initiative Speaker Series brings distinguished guest speakers to Tuck to discuss critical issues related to business and health care.

Class Visitor: Mr. Ethan Arnold - Founding Partner and Managing Director, The Chartis Group

• Date: 24 Oct
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 p.m.

Ethan Arnold is a founding partner and Managing Director of The Chartis Group. He has worked over the past nineteen years with healthcare providers and payers to improve their overall operating performance. Mr. Arnold has spent the last several years working as an advisor to the executive teams of some of the most prominent academic medical centers to focus on improving their underlying economics through both strategic and operational improvements.

Over the past several years, Mr. Arnold has worked with a number of leading academic medical centers, faculty practice plans and schools of medicine to improve alignment and overall operating performance. He has worked extensively with physician and hospital leadership to define expectation and improve performance in a number of areas including strategic planning, funds flow, ambulatory access, faculty practice design and operations, perioperative services, and inpatient access and throughput.

Prior to founding The Chartis Group, Mr. Arnold was a Partner at APM/CSC Healthcare, where he was one of the firm's leaders in developing the tools and methodologies in several different areas including: turnarounds, process centered redesign, supply chain, and patient access and revenue cycle.

Mr. Arnold formerly worked as a consultant in Cooper & Lybrand's health care practice where he provided financial and strategic consulting services to large scale payers, integrated delivery systems and long-term care facilities. While at Coopers, Mr. Arnold also worked with health insurance companies to redesign their operations including utilization management and provider enrollment.

Mr. Arnold has presented at numerous conferences on the topic of process centered management, revenue cycle improvement and overall trends in provider organizations. He has also worked with boards of specific institutions facilitating planning retreats and workshops on key strategic and operational issues facing provider organizations.

Mr. Arnold holds a Masters Degree in Public Health with a concentration in Hospital Administration from Yale University School of Medicine. His master's thesis was entitled "The Effectiveness of Mandatory State Rate-Setting Programs". Mr. Arnold also holds a B.A. in Chemistry from Lafayette College.

Class Visitor: Dr. Elliott S. Fisher - Director for Population Health and Policy, TDI

• Date: 24 Oct
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Dr. Elliott S. Fisher, MD/MPH

Director for Population Health and Policy, The Dartmouth Institute for Health Policy and Clinical Practice

James W. Squires, MD Professor at the Geisel School of Medicine

Dr. Fisher is the James W. Squires, MD Professor at Dartmouth Medical School and Director for Population Health and Policy at The Dartmouth Institute for Health Policy and Clinical Practice. He received his undergraduate and medical degrees from Harvard University and completed his internal medicine residency and public health training at the University of Washington. He is the director of the Dartmouth Atlas of Health Care and a member of the Institute of Medicine of the National Academy of Sciences.

His research has focused on exploring the causes of the two-fold differences in spending observed across U.S. regions and health care systems, on understanding the consequences of these variations for health and health care, and on the development and testing of approaches to performance measurement and payment reform that can support improvement. The research revealed that most of the differences in spending are due not to differences in health status, preferences, prices or poverty, but rather to greater use of discretionary services, such as the use of the hospital as a site of care and specialist referrals or diagnostic tests that would not have been ordered in lower spending regions. The findings that per-capita spending -- on these services -- is essentially uncorrelated with either quality or health outcomes highlighted the potential opportunity to improve the efficiency of U.S. health care.

His current policy work has focused on advancing the concept of "accountable care organizations" (ACOs) and includes co-directing, with Mark McClellan, a joint Brookings-
Dartmouth program to advance ACOs through research, coordination of public and private initiatives and the creation of a learning collaborative that includes several pilot ACO sites across the U.S.

Dartmouth-Hitchcock Heart and Vascular Center’s Grand Rounds on October 18th

• Date: 18 Oct
• Location: Dartmouth-Hitchcock Medical Center - Auditorium G
• Time: 5:00 p.m.

The Heart and Vascular Research Center (HVRC) at the Geisel School of Medicine and the Dartmouth Hitchcock Medical Center, in conjunction with the Tuck Healthcare Initiative, would like to invite all those interested in cardiovascular disease to the first of a monthly HVRC conference series. The event will be held at 5:00 pm October 18th in Auditorium G at Dartmouth Hitchcock Medical Center.

In the current research climate bringing together multidisciplinary teams is critical to developing innovative, impactful approaches to cardiovascular research and to the creation of competitive grant applications. The goal of this conference series is to foster these interdisciplinary collaborations. Each conference session will consist of two 20 minute presentations followed by 10 minutes of open discussion. Presentations will focus on the translational nature of the individual’s research, potential impact, and outstanding questions.

The first presentations will be:

• Dr. Aaron Kaplan, MD Professor of Medicine, Director of Device Development Section of Cardiology- The Physician-Scientist and the
  Development of Cardiovascular Devices: Bench to Clinical Trials
• Nicholas W. Shworak, M.D., Ph.D. Associate Professor of Medicine, Associate Professor of Pharmacology & Toxicology - Inflammation in cardiovascular disease

Sanofi Group: Sanofi & Genzyme Company Briefing for First-Year Students

• Date: 18 Oct
• Location: Tuck School - General Motors Classoom
• Time: 12:10 p.m.

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health.

Recruiting on-campus for: First-Year Students

Candidacy Requirements: Open to all candidates

McKinsey & Company Company Briefing for First-Year Students

• Date: 16 Oct
• Location: Tuck School - Georgiopolous Classroom
• Time: 6:00 p.m.

McKinsey & Company Company Briefing Georgiopoulos
Note: This briefing is for first year students.

Reception: To follow in Raether Atrium

Description: McKinsey & Company is a global management consulting firm. We are the trusted advisor to the world's leading businesses, governments, and institutions. We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world.

Recruiting On-Campus For: First-Year Students

Candidacy Requirements: Open to all candidates

Second‐Year Recruiting Break (no classes) October 15 - Friday, October 19

• Date: 15 Oct
• Location: Tuck School Of Business
• Time: 8:00 AM

IDEXX Laboratories Company Briefing for First Year Students

• Date: 11 Oct
• Location: Tuck School - Ankeny Classroom
• Time: 12:10 PM

Description: IDEXX Laboratories, Inc., is the global market leader in diagnostics and information technology solutions for animal health and water and milk quality.
Headquartered in Maine, IDEXX employs over 4,700 people in more than 60 locations around the world.

Recruiting for: First Year Students

Candidacy requirements: Open to all candidates

Eli Lilly Company Briefing for First and Second Year Students

• Date: 11 Oct
• Location: Tuck School of Business - General Motors Classroom
• Time: 12:10 PM

Description:  Lilly makes medicines that help people live longer, healthier, more active lives.

Founded by Eli Lilly in 1876, and now the 10th largest pharmaceutical company in the world, Eli Lilly has steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance their capacity to develop innovative medicines at lower costs.

Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity and respect for people.

Recruiting On-Campus for: First and Second Year Students

Candidacy Requirements: PWA required

Class Visitor: Austin Pittman - President, UnitedHealthcare Networks

• Date: 10 Oct
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 PM

Austin Pittman

President, United Healthcare Networks, UnitedHealthcare

Austin Pittman is President of UnitedHealthcare Networks and is responsible for managing UnitedHealthcare’s nationwide network of more than 650,000 physicians and health care professionals and over 5,100 hospitals. Austin and his team actively foster relationships with care providers across the country to ensure consumers enrolled in UnitedHealthcare’s individual, employer-sponsored, Medicare and Medicaid plans have access to affordable, high-quality care that is delivered by the broadest possible array of providers and hospitals.

Prior to this role, Austin served as Chief Growth Officer for UnitedHealthcare Employer & Individual, the largest business division within UnitedHealth Group, serving over 25 million consumers and managing health care benefits for individuals, public sector employers and businesses of all sizes.  He was appointed to that role in 2009 following several years of successful leadership positions within UnitedHealthcare’s local markets as health plan CEO of North and South Carolina and President of Texas and Oklahoma.

Austin is also very active in the community, serving on the Board of Directors for various organizations, including Inclusive Health, which serves both the North Carolina state risk pool and the federal risk pool; the Board of Trustees at McMurry University; and the University of North Carolina – Greensboro Board of Visitors.  He also served on the North Carolina Institute of Medicine Task Force on Prevention.

Austin received a Bachelor of Science from McMurry University in Abilene, Texas and a Master of Science in Business/Human Relations from Amberton University in Dallas.  Austin served in the United States Marine Corps and is now completing his Master of Health Care Delivery Science degree at Dartmouth College.

An avid chef at home, Austin is married and has four sons.

Class Visitor: Dr. Samuel Ho - Chief Clinical Officer for UnitedHealthcare and President of Clinical Shared Services

• Date: 10 Oct
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Samuel W. Ho, M.D.

Chief Clinical Officer and President of Clinical Shared Services

Dr. Sam Ho is currently Chief Clinical Officer for UnitedHealthcare, UnitedHealth Group’s health benefits division, and, as President of Clinical Shared Services, is responsible for the clinical advancement of 38 million members throughout the U.S., including enrollees in commercial, Medicare, and Medicaid health plans. He is the clinical executive specifically responsible for the execution of the quality improvement, medical management, care delivery transformation, performance measurement, transparency, and health care affordability programs throughout UnitedHealthcare and is also active in helping lead the value-based benefits and value-based provider payment programs.

Before joining UnitedHealthcare, Dr. Ho had extensive experience in leading medical affairs in other managed care organizations. Additionally, he served as deputy director of health, medical director and county health officer for the San Francisco Department of Public Health from 1988-1991. Dr. Ho had extensive experience in academic and family medicine and held clinical faculty appointments at both the Schools of Medicine and Nursing at the University of California, San Francisco. Moreover, in 1981, he founded the San Francisco Family Health Programs, which was a multi-disciplinary NGO providing clinical service to a neighborhood most underserved by health care resources.

A Honolulu native, Dr. Ho received his undergraduate degree from Northwestern University, with Phi Beta Kappa honors. He received his medical degree from Tufts University School of Medicine, and completed his residency in family medicine at the University of California, San Francisco.

About UnitedHealthcare

UnitedHealthcare is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers and Medicare and Medicaid beneficiaries, and contracts directly with more than 650,000 physicians and care professionals and 5,000 hospitals nationwide. UnitedHealthcare serves more than 38 million people and is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company, with over $100 billion in annual revenues.

Genentech Company Briefing for First and Second Year Students

• Date: 09 Oct
• Location: Tuck School - General Motors Classroom
• Time: 12:10 PM

Description: For more than 30 years, Genentech has been at the forefront of the biotechnology industry, using human genetic information to develop novel medicines for serious and life-threatening diseases. Today, Genentech is among the world’s leading biotech companies, with multiple therapies on the market for cancer and other serious medical conditions.

Our founders believed that hiring talented, enthusiastic people would make Genentech a success. Today, we still believe our employees are our most important asset. For this reason, we aim to provide employees with a stimulating and collaborative environment where they can make important contributions to medicine and thrive as professionals.

Recruiting on-campus for: First and Second Year Students

Candidacy requirements: Open to all candidates

Danaher Corporation Company Briefing for First Year Students

• Date: 09 Oct
• Location: Tuck School - General Motors Classroom
• Time: 5:10 PM

Description: Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve.

Recruiting on-campus for: First Year Students
Candidacy requirements: PWA required to bid

Joe Zubretsky, Senior Executive Vice President and Chief Financial Officer of Aetna, to Speak at Tuck on the Future of the Health Care Industry

• Date: 09 Oct
• Location: Tuck School - General Motors Classroom
• Time: 12:00 p.m.

Joseph M. Zubretsky, Senior Executive Vice President and Chief Financial Officer, joined Aetna, Inc. in February 2007. In his position, he leads all of the corporation’s financial activities, including financial and performance management, capital strategy and planning, investor relations as well as corporate development, investment management, strategic planning and Aetna’s strategic diversification businesses. He is a member of the Executive Committee, the senior governing body of the company, and is a key strategic contributor.

Mr. Zubretsky came to Aetna from UnumProvident Corporation, where he was Senior Executive Vice President of Finance, Investments and Corporate Development. In that capacity, he was responsible for Unum’s financial operations and capital management, investment management operations, enterprise risk management, and strategy development and planning.

Prior to Unum, Mr. Zubretsky was President and Chief Executive Officer of GAB Robins Group, a global insurance services company, for over six years. Concurrently, he was a partner with New York-based private equity firm, Brera Capital Partners, specializing in insurance industry investments. He has also served as executive vice president of business development and chief financial officer of MassMutual Financial Group, executive vice president and chief financial officer of Healthsource, Inc, and as a partner in the firm of Coopers & Lybrand.

Mr. Zubretsky is a native of Hartford and graduated from the University of Hartford where he received a Bachelor of Science in Business Administration.

N.H. Health Care - Is There Good News?: An ILEAD Discussion Event in Collaboration with NH Public Television and DHMC Centers for Health and Aging

• Date: 09 Oct
• Location: File Auditorium
• Time: 4:00 p.m.

Everyone needs access to some form of health care, but not everyone has means to pay for it. Using the film as a catalyst, we will ask the question: "N.H. Health Care - Is There Good News?" The ensuing conversation is designed to help people continue to ask that question with their friends, families, physicians, representatives and policy makers. By shedding light on these innovations and bright spots in our own state, we hope to make the connection that what is happening across the country to make healthcare more affordable and accessible, can, in fact, happen here.

Panelists:

• Dr. Stephen Bartels - Centers for Health and Aging, Dartmouth-Hitchcock Medical Center
• Barbara Couch - Vice President of Corporate Responsibility, Hypertherm
• Rushika Fernanadopulle - CEO, IORA Health
• Denise Anthony - Dartmouth Sociology Department - Associate Professor
• Jeanne Ryer - Director of NH Citizens for Health Initiative - Moderator

While this event is free and open to the public, you must register to attend: ILEAD@dartmouth.edu, (603)-646-1413.

www.dartmouth.edu/~ilead

The Chartis Group Company Briefing for First and Second Year Students

• Date: 08 Oct
• Location: Tuck School - Rosenwald Classroom
• Time: 12:10 PM

Description: The Chartis Group is a boutique advisory services firm that provides management consulting and applied research to leading US healthcare delivery organizations, including academic medical centers, children’s hospitals and large hospital systems. Our clients include Kaiser Permanente, Stanford University Medical Center, Barnes Jewish Hospital, University of Pennsylvania Health Systems and St. Jude Children’s Research Hospital.

To support its growth, the Firm is committed to attracting a limited number of highly qualified and talented individuals.

Recruiting on-campus for: First and Second Year Students
Candidacy requirements: PWA required

Class Visitor: Dr. Raymond Zastrow - Chief Medical Officer, QuadMed

• Date: 03 Oct
• Location: Tuck School - Shapiro Classroom
• Time: 4:45 PM

Raymond J. Zastrow, M.D., F.A.A.F.P.

Chief Medical Officer - QuadMed

Dr. Zastrow received his M.D. from the Medical College of Wisconsin in 1983. He completed his Family Practice residency at the University of South Carolina School of Medicine in 1986, and returned to Milwaukee where worked in private practice with various divisions of Advanced Healthcare until 2006 when he joined QuadMed as Associate Corporate Medical Director.

He assumed the role of President on Feb 1, 2008. QuadMed provides on-site, employer-directed primary care, prevention and wellness to Quad/Graphics, Miller Brewing and Briggs & Stratton. Dr. Zastrow is responsible for clinical quality oversight, clinical process re-design including deployment of GE Centricity electronic medical records, and assists with healthcare benefit design for Quad/Graphics.

Prior to joining QuadMed, Dr. Zastrow served in several administrative roles. From 1994 to 2001 he was Medical Director of Informatics for the Wheaton Franciscan System. From 2001 to 2004 Dr. Zastrow served in the role of Vice President of Medical Affairs for St. Michael Hospital. In addition, since 1988 he has provided care to a small population of Long-term Care patients at Golden Living Center / Bradley in Milwaukee – where he is also the facility’s Medical Director.

An Instructor in the Medical College of Wisconsin / Milwaukee School of Engineering Master of Science in Medical Informatics graduate degree program, Dr. Zastrow teaches Healthcare Decision Support. He is a founding board member and vice president of the Center for Health Value Innovation.

Thermo Fisher Scientific Company Briefing for Second Year Students

• Date: 01 Oct
• Location: Tuck School - Rosenwald Classroom
• Time: 12:10 PM

Description: Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Recruiting On-Campus for: Second Year Students

Candidacy requirements: PWA required

Note: This briefing is for second years. There will be another briefing for first years on 11/13/2012.

Company Representatives:
Brenden Beckstein, Director, Learning and Development
Anand Mamidipudi T'08, Product Line Manager

Cerner Company Briefing for Second Year Students

• Date: 27 Sep
• Location: Tuck School - Danziger Classroom
• Time: 5:10 p.m.

Cerner Company Briefing
Open Exchange to follow

Description: Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities.

We are transforming health care by eliminating error, variance and waste for health care providers and consumers around the world. Our solutions optimize processes for health care organizations ranging from single-doctor practices to entire countries, for the pharmaceutical and medical device industries, and for the field of health care as a whole. Our solutions are licensed by more than 9,000 facilities worldwide.

Health care is too important to stay the same.

We invite you to join us in our quest to make health care become all it should be. Since our company began, we have been committed to transformational change in the vital task of keeping people well. Now more than ever, our focus is on developing the innovations that will help improve the entire health care system. Ultimately, as our CEO Neal Patterson has said, “health care is personal.” Because in the end, nothing matters more than our health and our families.

Recruiting On-Campus for: Second Year Students

Candidacy Requirements: PWA Required

Company Representatives:

• Johnny Kaye T'12, Business Strategist, Executive Development Program (2011-2012 Healthcare Club Officer)
• Matt Obenhaus T'10, Business Strategist, Executive Development Program

http://www.cerner.com/

Class Visitor: Paul Mango - Director, Pittsburgh Office & Former Director of the Global Health Care Practice, McKinsey & Company

• Date: 26 Sep
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Paul Mango

Director, Pittsburgh Office - McKinsey & Company

Former Director of the Global Health Care Practice - McKinsey & Company

Paul Mango is a Director in the Pittsburgh office of McKinsey & Company. He led the Global Health Care Practice from 2003 to 2011.

Paul has led recent health care engagements spanning a broad spectrum of strategy, operations, and organization topics, with an increasing emphasis on health reform, the impact of consumer-directed health, development of distinctive service strategies, application of lean manufacturing principles to patient care delivery processes, and medical tourism. He works extensively with some of the country’s largest health insurers and provider organizations and has also spent a significant amount of time serving health care clients in Europe, Asia, and the Middle East. Paul is currently leading McKinsey's efforts to understand the implications of health reform legislation on health insurers, providers, and employers.
Prior to joining McKinsey in 1988, Paul served five years as a field artillery officer in the US Army. Paul's formal education includes a General Engineering degree from West Point where he graduated as a distinguished cadet in 1981, and a Masters in Business Administration from Harvard University where he graduated as a Baker Scholar in 1988. Paul is currently an Advisory Board Member for the Leonard Davis Institute for Health Economics at the University of Pennsylvania.

Easton Associates Company Briefing for Second Year Students

• Date: 25 Sep
• Location: Tuck School - Rosenwald Classroom
• Time: 12:10 PM

Description: Easton Associates’ founding partners, former executives of The Wilkerson Group, each have over 20 years of healthcare consulting or industry experience, and collectively, have completed thousands of strategic planning, opportunity assessment, corporate development, and due diligence engagements in virtually every segment of the biomedical industry.

Since EA’s inception in 2000, company growth has been fueled by our ability to attract exceptional professionals with strong management consulting and life science backgrounds to our staff. The experience of our senior staff, composed of MBAs, PhDs, and MDs, is a particular strength, and in contrast to the rapid turnover typical of the consulting industry, the majority of our engagement managers have been with the firm five years or longer. We are located in New York, London, and Beijing.

Recruiting On-Campus for: Second Year Students

Candidacy Requirements: PWA required

3M Company Briefing for First and Second Year Students

• Date: 25 Sep
• Location: Tuck School - Borelli Classroom
• Time: 12:10 p.m.

Recruiting On-Campus for: First and Second Year Students

Candidacy requirements: PWA Required

Company Representatives:

• Holly Rosenblum T'10
• Thanh Tu

Film Screening: ESCAPE FIRE: The Fight to Rescue American Healthcare

• Date: 20 Sep
• Location: Tuck School - Georgiopolous Classroom
• Time: 7:00 p.m.

Courtesy of the Escape Fire Website: http://www.escapefiremovie.com/

American health care costs are rising so rapidly that they could reach $4.2 trillion annually, roughly 20% of our Gross Domestic Product, within ten years. We spend $300 billion a year on pharmaceutical drugs almost as much as the rest of the world combined. We pay more, yet our health outcomes are worse. About 65% of Americans are overweight and almost 75% of health care spending goes to preventable diseases that are the major causes of disability and death in our society.

It's not surprising that health care is at the top of many Americans concerns and at the center of an intense political firestorm in our nation's capitol. But the current battle over cost and access does not ultimately address the root of the problem: We have a disease-care system, not a health care system. The film examines the powerful forces maintaining the status quo, a medical industry designed for quick fixes rather than prevention, for profit-driven care rather than patient-driven care.

Escape Fire also presents attainable solutions. After decades of resistance, a movement to bring innovative high-touch, low-cost methods of prevention and healing into our high-tech, costly system is finally gaining ground. Filmmakers Matthew Heineman and Susan Froemke interweave dramatic personal arcs of patients and physicians with the stories of leaders battling to transform health care at the highest levels of medicine, industry, government, and even the U.S. military. Escape Fire is about finding a way out of our current crisis. Its about saving the health of a nation.

Biogen Idec Company Briefing For First and Second Year Students

• Date: 19 Sep
• Location: Tuck School - Frantz Classroom
• Time: 12:10 PM

Description: Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. We are the world's oldest independent biotechnology company and a Fortune 500 company with more than $4 billion in revenues. Patients worldwide benefit from our products.

Biogen Idec helped create an industry that has touched countless lives. We were among the world's first biotechnology companies, and today we are the oldest independent biotech firm in the world.

Recruiting on-campus for: First and Second Year Students
Candidacy requirements: PWA Required

Class Visitor: Elizabeth Teisberg - Professor, Department of Community and Family Medicine at the Geisel School of Medicine

• Date: 19 Sep
• Location: Tuck School of Business - Shapiro Classroom
• Time: 4:45 PM

Elizabeth Teisberg, Ph.D., M.Engineering

Professor - Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth

Senior Institute Associate, Institute for Strategy and Competiveness at Harvard Business School

Dr. Teisberg will serve as a visiting executive in the fall Tuck elective, Medical Care and the Corporation and will speak on the topic of Business Responses to Health Care Challenges. 

Her expertise is in Strategy and Innovation. Professor Teisberg speaks and works internationally on innovation for dramatic improvement in health care value, actively implementing Redefining Health Care. She has developed frameworks and cases to enable the implementation of health care delivery transformation.

Redefining Health Care received the American College of Healthcare Executives 2007 James A. Hamilton book of the year award. At UVA, Professor Teisberg also received the Frederick S. Morton Leadership Award in 2004 and the Wachovia Award for research excellence in 2006. Prior to joining the faculty at the Darden School of Business, she was an associate professor in the Strategy Group at the Harvard Business School.

In addition to Redefining Health Care, Professor Teisberg co-authored with Michael Porter five articles on health care, as well as a Harvard Business Review Special Report 'Fixing Competition in U.S. Health Care'. Professors Teisberg and Porter have also developed courses on Health Care Delivery that they co-teach at Harvard University. At the University of Virginia, Professor Teisberg taught Innovation and Health Care Management. She also teaches executive education at both Harvard and UVA, as well as on-site for companies and organizations. Professor Teisberg's earlier projects have analyzed strategy in medical device and biotech companies, real options, research and development decisions, medical innovation, and strategic response to uncertainty.

Professor Teisberg is the author or co-author of over 50 cases and articles in professional publications such as the Harvard Business Review, Journal of the American Medical Association, Science, Seminars in Thoracic and Cardiovascular Surgery, Rand Journal of Economics, Management Science, Research-Technology Management, and Interfaces. She is the co-author of The Portable MBA, which has been published in five languages.

Professor Teisberg earned a M.S. and a Ph.D. in engineering-economic systems from the Stanford University School of Engineering. She also holds a M. Eng. in systems science from the University of Virginia and an A.B. degree, summa cum laude, in political science and mathematics from Washington University in St. Louis. She is a member of Phi Beta Kappa.

Trinity Partners Company Briefing for First and Second Year Students

• Date: 18 Sep
• Location: Tuck School - Frantz Classroom
• Time: 5:10 PM

Description: Trinity Partners, LLC (“Trinity”) is a leading life sciences consulting firm that provides strategic and tactical insights to clients worldwide. Our clients are among the most successful firms in the industry and include a mix of pharmaceutical, biotechnology, medical device, and diagnostic companies. Blending consulting services with research capabilities, we specialize in corporate strategy, pipeline & portfolio optimization, brand planning, market analytics, promotional effectiveness, and licensing & acquisition. Based just outside Boston, Massachusetts, Trinity employs about 90 professionals, and has an office in New York City.

Recruiting On-Campus for: first and second year students

Candidacy Requirements: open to all candidates

Bank of America Merrill Lynch Company Briefing for First Year Students

• Date: 18 Sep
• Location: Tuck School - Barclay Classroom
• Time: 5:10 PM

Description: Corporate & Investment Banking serves as a trusted advisor to premier corporate, institutional and government clients, helping them develop their strategic objectives and meet their financial needs. The group provides advice, financing, and services to these clients throughout the world.

Organized by industry sector, investment bankers are dedicated to understanding the unique competitive and operating environments of our clients, and to building strong, enduring client relationships. We are primarily organized into 11 industry/product teams focused on specific sectors. These include: Consumer & Retail; Corporate Finance; Energy & Power; Financial Institutions; Financial Sponsors; Industrials; Health Care; Mergers & Acquisitions; Real Estate, Gaming & Lodging; Technology, Media & Telecom.

What’s our strategy for success? It starts and ends with serving our clients the solutions and execution they need in today’s market. Award winning execution - Our product origination specialists work closely with industry bankers, sales and trading to develop creative solutions for our clients. We set ourselves apart by delivering innovative ideas and strategies, advanced technology and objective, timely analysis covering a large universe of companies, industries, products and geographies.

Recruiting on-campus for: First Year Students
Candidacy requirements: Open to all candidates

Bristol-Myers Squibb Company Briefing for First Year Students

• Date: 18 Sep
• Location: Tuck School - General Motors Classroom
• Time: 12:10 PM

Description: We are a team dedicated to extending and enhancing human life, committed to our patients and focused on finding innovative medicines to combat serious diseases and address unmet medical needs. By combining the reach and resources of a global pharmaceutical company with the can-do spirit and agility of a biotechnology company, we are becoming a leader for the future – a next-generation BioPharma leader. Our vision requires bold leaders. People like you.

Recruiting on-campus for: First Year Students
Candidacy requirements: PWA Required
 

Sector Smarts Health Care Panel

• Date: 18 Sep
• Location: Tuck School of Business - Stoneman Classroom
• Time: 2:30 PM

Healthcare Initiative Co-Executive Director and Director of the MD-MBA Program, Donald P. Conway will serve as the Health Care Panel Moderator.  The following alumni have tentatively signed-on to participate:

Errik Anderson T’07, ADiMaB
Cori Lewis T’09, Chartis Group
Kris Hager T’10, Bristol-Myers Squibb
Jill Branca T’07, Biogen Idec

Tuck Centers and Initiatives Information Session

• Date: 13 Sep
• Location: Tuck School - Georgiopoulos Classroom
• Time: 12:00 PM

Tuck’s centers and initiatives bring a cross-disciplinary focus to the issues that drive today's economy. They leverage faculty research, enrich the curriculum and learning environment for students, and connect the school more directly with practitioners and thought leaders in each field. Each sponsors its own programs and qualified MBA students are invited to serve as fellows, research associates, roundtable members, or participants in independent study projects. Representatives from Tuck Centers and Initiatives will be on-hand to discuss their respective center/initiative offerings and how first year students may become involved.